Family history in young and middle-aged acute ischemic stroke patients. The Norwegian Stroke in the Young Study by Øygarden, Halvor
Dissertation for the degree of philosophiae doctor (PhD)  
at the University of Bergen 
Dissertation date: 
© Copyright Halvor Øygarden 
The material in this publication is protected by copyright law.  
 
Year:  2016 
Title:  Family history in young and middle-aged acute ischemic stroke patients 
  The Norwegian Stroke in the Young Study 
Author:  Halvor Øygarden 
Print:  AiT Bjerch AS / University of Bergen 
 
3
Scientific environment  
The work constituting this thesis has been carried out at the Department of 
Neurology, Haukeland University Hospital. Facilities, equipment, training and 
support have been provided and carried out at the Department of Neurology, 
Haukeland University Hospital, in collaboration with and support from the Bergen 




List of abbreviations 9
Abstract 10
Introduction 11
Ischemic stroke at a young age and cardiovascular disease 12 
Definition of stroke and cerebral ischemic arterial stroke 12 
Definition of young stroke 13
Cardiovascular disease 14
Epidemiology 15 
The global burden of cardiovascular disease 15
Impact and costs of stroke 19
Reducing the burden of cardiovascular disease 21
Time trends in stroke incidence – the age disparity 23 
Etiology and risk factors 27 
Etiology of stroke 27 
Atherosclerosis 28 
Traditional risk factors for stroke in the young 29
Rare risk factors for stroke in the young  33
Secondary prevention and prognosis 35 
Sex differences in stroke 37 
Family history 39 
Family history and cardiovascular disease  39 
Family history and stroke 41 
Genetics in cardiovascular disease  46 
Verification of the family history 47 
Carotid intima-media thickness and cardiovascular disease  49
5
Carotid intima-media thickness 49 
Methods of measuring carotid intima-media thickness 49 
List of publications 55
Aims of the thesis 56
Subjects and methods 57
The Norwegian Stroke in the Young Study  57 
Bergen NORSTROKE  58 
Carotid intima-media thickness  58 
Risk factor definitions  59 
Family history  60 
Participation and number of subjects  61 
Statistical analyses 62 
Ethical considerations  63 
Summary of included papers 64
General discussion 68
Demographics of the NOR-SYS cohort  68 
Age and sex 68 
Education and work  69 
Anthropometric, biologic and behavioral risk factors 70 
Family history data  71 
Family history of cardiovascular disease in young and middle aged 
ischemic stroke patients  72 
Age and family history of cardiovascular disease  75 
Second generation family history  78 
Effect of sex on the family history  79 
Knowledge of stroke vs. heart disease  81 
A history of stroke – ischemia or bleeding  82 
How to get the most reliable family history  84 
6
Value of family history  86
Family history and carotid intima-media thickness  87 
Conclusions and future directions 90
Source of data 92
Appendix 110
Errata 116 
Paper I – III  117 
7
Acknowledgements 
I would like to start by giving my sincere gratitude to my main supervisor Associate 
Professor Ulrike Waje-Andreassen and my co-supervisor Professor Lars Thomassen. 
They possess a vast knowledge and experience in the field of stroke. Their 
unquenchable enthusiasm to increase research and expand knowledge in the field of 
stroke has been truly inspiring and may only be surpassed by their ability to inspire 
this thirst for knowledge in others. The everlasting support, encouragement and 
critical revisions they provide have been indispensable in the work of producing this 
thesis.  
I am forever beholden to Professor Ole-Bjørn Tysnes, head of Department of 
Neurology, Haukeland University Hospital and Professor Nils Erik Gilhus, head of 
Department of Clinical Medicine, University of Bergen, for providing me the 
opportunity to carry out this thesis. 
It was an exciting opportunity to be included in the extremely enthusiastic Bergen 
Stroke Research Group when I finished my MD. The fast paced and highly 
productive research environment driven by so many intellectual powerhouses got me 
smitten in an instant. I owe a big thank you to Professor Halvor Næss for the 
inspiration he has given me in stroke research, and in setting an example of 
unsurpassed effectivity in both clinical and academic work.  
I am grateful to Dr. Annette Fromm for teaching me the know-how of NOR-SYS and 
neurovascular ultrasound. Your expertise and clinical skills in wielding the 
ultrasound probe has been an inspiration and a goal to aspire towards. I am also 
grateful to Dr. Kristin Modalsli Sand who has been a valuable colleague to share 
work and rewarding conversations with. I would like to provide thanks to Geir Egil 
Eide for giving valuable feedback and advice with regards to the statistical analyses 
and interpretations. 
8
I am grateful for the invaluable work of administrating the NOR-SYS study carried 
out by Jeanette Antoniazzi and the study nurses at the Department of Neurology, Linn 
Elin Rødal and Toril Bjørgo. 
In my research I have had the opportunity to work on conjoining fields of stroke 
research and in this collaborate with several brilliant researchers. I would like to 
mention Dr. Christopher Elnan Kvistad and Dr. Nicola Logallo who have been and 
continue to be invaluable in keeping the working environment joyful and playful 
through hectic and busy times. I would also like to thank Dr. Eivind Kolstad for 
valuable and exciting conversations about research, football and life in general.  
My parents greatly inspire me. Your care and love for the people around you gave me 
the inspiration to become a doctor. I cherish your good advice and your inexhaustible 
love and support for me and my family. To my sister Maria and my brother Eirik, 
thank you for every argument, every hug, every fight, every laugh, and every tear we 
have shared.  
To my parents-in-law Siri and Alf Ivar: Thank you for all your help and your loving 
care for all of us.   
To the love of my life, Christine, you make me a better me. I would not be the man I 
am without you. Thank you for always supporting me, and thank you for being the 
best wife and mother I can imagine.  
To my diamonds Herman, Cornelia and Carla, you make every day brighter and you 
have my eternal love.  
9
List of abbreviations and acronyms
ABI   Ankle-brachial index 
AHA   American Heart Association 
ASA   American Stroke Association 
ASCO Acronym for a stroke etiology classification system: 
Atherosclerosis, Small vessel disease, Cardiac source and Other 
source 
BIF   Carotid artery bifurcation 
BP   Blood pressure 
CCA   Common carotid artery 
CCS    Causative Classification System  
CHD   Coronary heart disease 
CI   Confidence interval 
cIMT   Carotid intima-media thickness 
CNS   Central nervous system 
CT   Computed tomography 
CVD   Cardiovascular disease 
DM   Diabetes mellitus 
DWI   Diffusion weighted imaging 
FH   Family history 
FHS    Framingham Heart Study 
GWAS  Genome-wide association study 
HT   Hypertension 
HR   Hazard ratio 
ICA   Internal carotid artery 
ICH   Intracerebral hemorrhage 
i.e.   id est (that is) 
IS   Ischemic stroke 
MI   Myocardial infarction 
MRI   Magnetic resonance imaging 
NOR-SYS  The Norwegian Stroke in the Young Study 
OR   Odds ratio 
OXVASC  Oxford Vascular Study  
PAD   Peripheral artery disease 
RR   Relative risk 
TIA   Transient ischemic attack 
TOAST  Trial of Org 10172 in Acute Stroke Treatment classification  
WHO   World Health Organization 
10
Abstract 
Cardiovascular disease (CVD), including stroke, coronary heart disease (CHD) and 
peripheral artery disease, is the leading cause of death and disability in the western 
world. CVD is influenced by genetic and lifestyle factors. Knowledge about heredity 
is well documented for CHD. However, the influence of a positive family history 
(FH) on stroke is far less documented.  
The studies included in this thesis therefore aim to quantify and evaluate a detailed 
FH of CVD in a young ischemic stroke population with a special regard to sex 
differences.  Further, we aimed to verify the patient reported family history by 
comparison with parental reports, and to find factors associated with best accuracy of 
the patient reported FH. In addition we aimed to analyze if a positive FH of CVD is 
associated with intima-media thickness (IMT) and plaque measurements, performed 
at standardized sites in the carotid arteries.  
A total of 59% of our patients reported ischemic CVD events among their first degree 
family members. Females were three times more likely to report a positive FH than 
males and knowledge of FH was higher in relatives with a female than male linkage. 
Detailed knowledge on FH was better for CHD than for stroke. The FH reported from 
patients were in good concordance with parental reports, but with a slightly decreased 
accuracy from patients aged over 45 years.  FH of stroke was associated with higher 
internal carotid IMT in young ischemic stroke patients. The association was strong 
for young patients, and absent in the highest age group from 50-60 years.  
In conclusion, data presented in this thesis, add new information to the field of young 
stroke by a detailed FH of CVD and detailed ultrasound diagnostics of the carotid 
arteries. Thorough diagnostics after ischemic stroke and the history of ischemic CVD 




Cardiovascular disease (CVD) is mainly composed of three disease subgroups 
associated by a pathophysiologic basis of atherosclerosis, namely ischemic stroke, 
coronary heart disease and peripheral artery disease. CVD in general and stroke in 
particular are traditionally considered to be diseases of the elderly. True to some 
extent as incidence of stroke rises exponentially with age. However, stroke in the 
young deserves attention. Though less frequent than stroke at higher age, stroke at a 
young age can be detrimental for the individual suffering stroke and may be a big 
burden on the patient’s family. In addition, stroke entails high societal costs with 
respect to treatment, rehabilitation and subsequent disability.   
Worryingly, the steep decline seen in incidence rates of stroke in the elderly, is absent 
in the young. Some reports even suggest an opposite trend, with increasing incidence 
of stroke in young patients. Decreasing the incidence of stroke in the young therefore 
requires new approaches and other methods of identifying increased risk. A part of 
the solution may be a better understanding of the inherited risk of stroke.  
Family history (FH) is a well-known risk factor for coronary heart disease. However, 
the role of FH as a risk factor for ischemic stroke is less clear. Several studies have 
shown that a positive FH does increase the risk of ischemic stroke, whereas others 
have not. The FH is an inexpensive and easily accessible tool to assess the heredity of 
disease. However, many years of research on the topic of FH and stroke leave us with 
few clear answers. FH has usually been considered positive if any family member had 
CVD, even the studies investigating only a FH of stroke have mostly not separated 
ischemic from hemorrhagic stroke.  Diagnostics of stroke have improved 
considerably during the past 25 years, and we may now analyze the FH with greater 
precision.  
Can the family history provide a contribution to understanding ischemic stroke?  
12
Ischemic stroke at a young age and cardiovascular 
disease  
Definition of stroke and cerebral ischemic arterial stroke 
The traditional WHO definition of stroke is “rapidly developing clinical signs of focal 
(or global) disturbance of cerebral function, lasting more than 24 hours or leading to 
death, with no apparent cause other than that of vascular origin”. 1-3 However, 
increased use of Magnetic Resonance Imaging (MRI) made this definition imprecise, 
thereby prompting the work towards a global consensus on a new definition. 4 The 
new definition incorporates specific pathophysiologic causes of stroke and imaging. 
However, as the access to imaging; especially magnetic resonance imaging varies 
considerably around the globe; this definition has yet to be globally endorsed. 5 The 
definition proposed by American Heart Association/American Stroke Association 
(AHA/ASA) is presented in table 1. 
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The new definition expands on the tissue based definition of TIA by defining 
pathological imaging as a central part of diagnosis and allows infarctions in the entire 
CNS. This definition harmonizes more with the currently used definitions of coronary 
heart disease (CHD). 4,6 Stroke includes both hemorrhagic and ischemic stroke, but 
the link with atherosclerosis is strongest for ischemic stroke. Ischemic stroke and 
intracerebral hemorrhage co-exist under the same diagnostic umbrella of stroke 
mainly due to historical reasons. Before the age of cerebral imaging, when autopsy 
was the only diagnostic aid able to separate between cerebral ischemia and cerebral 
hemorrhage, the similar symptomatology of palsy and other cerebral deficits led to 
the compounding of both entities as “apoplexy” or stroke. However, risk factors and 
the mechanism of tissue damage differ. Acute and preventive treatment is profoundly 
different and prognosis for brain hemorrhage is in general worse than for ischemic 
stroke. We now have widespread excellent diagnostic possibilities, able to separate 
hemorrhage from infarction, and even arterial ischemic stroke from cerebral ischemic 
damage caused by sinus venous thrombosis. The new definition underlining and 
acknowledging these differences is therefore most welcome. 
Definition of young stroke 
A clear and definite definition of young stroke is lacking. Different age limits for the 
definition of young stroke have been used in prior studies. The majority of studies 
have considered 45 years as the upper age limit defining young patients 7-13 but 
differences are apparent with several studies using <50 years 14-18 and others applying 
even higher age limits of 55 years. 19-22 The different definitions may cause variations 
in reported incidence rates, distribution of stroke etiology and risk factor prevalence 
in the young stroke population, as these distributions vary with age. 23,24 NOR-SYS 
expanded the definition of “young” to account for the high life-expectancy of over 80 
years in Norway, and the normal retirement age of 67 years for both sexes. The 
present thesis defines young stroke as stroke occurring before 45 years of age, while 




Cardiovascular diseases are diseases involving the heart and the blood vessels. The 
three main groups with atherosclerosis as main underlying pathophysiological 
mechanism are ischemic stroke, and especially CHD and peripheral artery disease 
(PAD). 25 The common mechanism is inflammation and development of 
atherosclerosis in the arteries that may lead to thromboembolic complications and 
ischemic damage of tissue. These three disease subgroups are considered to overlap 
in pathophysiology and one diagnosis carries an increased risk of the other two. 26,27
In addition, congenital heart disease, rheumatic heart disease, cardiomyopathies and 
cardiac arrhythmias are also considered CVDs, however caused by various different 
underlying mechanisms. 25 The type of tissue that is damaged and the 
symptomatology in ischemic stroke, CHD and PAD may differ substantially, but the 
final mechanism of damage for these three CVD subgroups is essentially the same 




The global burden of cardiovascular disease 
Cardiovascular disease, mainly composed of cerebrovascular disease, ischemic heart 
disease and peripheral vascular disease, causes a large part of the total global burden 
of disease. An estimation of cause of death around the globe reported CVD as the 
cause of more than 17 million deaths in 2013. 28 Cerebrovascular disease and 
ischemic heart disease was the cause of more than 26% (14.6 million of 54.9 million 
in total) of global deaths in 2013 (Table 2). 28 Both stroke and myocardial infarction 
(MI) are now ranked within the top three global causes of death and years of life lost, 
as their relative impact have increased through recent decades (Figure 1).  
The pattern of CVD as the largest cause of years of life lost is apparent with small 
variations in most parts of the globe, with the exception of sub-Saharan Africa 




However, this seemingly dramatic increase can to a great extent be explained by 
population growth and a shift in population demographics, with an ageing population 
in most parts of the world. By comparison, the global age-adjusted death rates due to 
CVD actually fell by 22% in the same period. However, large differences in 
improvement are seen between the developed and developing world. E.g. some high-
income countries such as Denmark, Norway, South Korea, UK and Israel have seen 
reductions in adjusted death rates exceeding 65%. 28 The wealthy countries that 
experience improvement greatly exceeding the global average are contrasted by the 
poor countries seeing less improvement and some even seeing increased death rates 
due to CVD. 28 In 2012 the reported rate of death due to CVD per 100 000 Norwegian 
adults between 35 and 74 years were 136 in males and 53 in females, of which stroke 
accounted for 23 and 15 deaths, respectively, these numbers are based on ICD-codes 
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and data from WHO and national health authorities. 29 Improved and more detailed 
statistics from Norway will be available with reports from the Norwegian stroke 
registry that started collecting nation-wide data in 2013. 30 Disparities in stroke 
incidence between high-income and low to middle-income countries increased 
between 1990 and 2010 as the age-standardized incidence of stroke was decreased by 
12% in high-income countries whereas a 12% increase was seen in low and middle-
income countries. 31  
A normal body-mass index (BMI) is important to maintain optimal cardiovascular 
health and increased BMI is associated with increases risk of both ischemic stroke 
and coronary artery disease independently of high blood pressure, high cholesterol, 
and high glucose. 32 There has been an increase in BMI in most parts of the globe, 
contributing to increased rates of CVD. 33 Increasing BMI is also closely linked with 
hypertension and diabetes mellitus, and the increasing prevalence of this risk factor 
complex inspired a quite worrying prediction from Circulation: “The changing 
associations of metabolic risk factors with macroeconomic variables indicate that 
there will be a global pandemic of hyperglycemia and diabetes mellitus, together with 
high blood pressure in low-income countries, unless effective lifestyle and 
pharmacological interventions are implemented.” 34 This prediction infers that CVD 
will continue to cause an increasing proportion of years of life lost (YLL) and thus 
the trend seen in figure 1 with CVD conquering higher places on the ranking of top 
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The incidence of first ever stroke in Norway was calculated at approximately 11 000 / 
year in 2007. 37 The annual incidence of ischemic stroke in Western Norway was 
investigated in the years between 1988 and 1997 with a reported average annual 
incidence of 11.4 / 100 000 in the group aged 15-49 years. 38
Though less frequent than stroke at higher age, stroke at young age is a serious event. 
Research in Hordaland in 2004/05 showed that first ever ischemic stroke patients 
aged < 50 years have 10x higher mortality rates than controls at mean follow up of 12 
years and 27% of these young ischemic stroke patients were deceased after a follow 
up of 18 years. 39 In populations of predominantly European descent the incidence 
rates between 15-45 years are approximately 10-20 per 100 000 person-years. 40-42
Twice as high incidence rates are observed in blacks and even higher rates are 
reported in developing countries. 31,41,43  
The estimated direct medical cost of stroke in the US was US$ 22.8 billion in 2009. 44
Estimating the combined cost of treatment, rehabilitation, disability, subsequent need 
of nursing and absenteeism from work due to stroke amounted to more than € 64 
billion in Europe in 2010. 45 The estimated costs of stroke in low-income and middle-
income countries are considerably lower compared to high-income countries, though 
large variations between countries exist, from the lowest estimate of US$ 416 per 
stroke in Senegal up to US$ 8 424 per stroke in Nigeria. 46 The average cost of one 
incident stroke in Europe as a whole was estimated to € 21 000 while the yearly cost 
of a prevalent stroke was estimated to € 5 368 in 2010. 45 Similar estimates have been 
published in France 47 and Ireland 48.  
A Norwegian estimate from 2007 reported costs of NOK 150 000 – 170 000 the first 
year after stroke and a lifetime cost of NOK 600 000 per stroke. 49 However, the 
authors found insufficient data to assess the cost of stroke in Norway directly and 
based their numbers in large part on a previous Swedish estimate. 50 The factors with 
the most influence on cost of stroke are age at onset, comorbidities and severity of 
stroke and subsequent disability. 51 The total cost of a stroke is notably higher in 
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both acute treatment and CVD preventive measures, combined with the 
implementation of public health measures to increase awareness and knowledge of 
disease and risk factor reduction in the public. 53 The considerable success of 
achieving the principal goals of 25 % mortality reduction for 2010 inspired Impact 
Goals for 2020 stating: “By 2020, to improve cardiovascular health of all Americans 
by 20 percent, while reducing deaths caused by CVD and stroke by 20 percent”. 44
However, they also acknowledged that achieving the goals of reducing smoking and 
physical inactivity and the goal to maintain obesity and diabetes mellitus at baseline 
levels were harder to achieve. 53 Therefore the 2020 impact goals emphasize 
cardiovascular health improvement as the primary means to achieve the goals of 
mortality reduction. The AHA/ASA saw the need for additional focus on preventive 
measures and suggested new metrics were designed to aid improvement and ensure 
attention be paid to the most critical issues. 53 This work resulted in the identification 
of three medical metrics, consisting of BP, total serum cholesterol and blood glucose, 
and four behavioral metrics, consisting of smoking, BMI, physical activity and diet, 
considered as key elements in the assessment of cardiovascular health. 53 These 
metrics combined were coined “Life’s Simple 7” and defined the areas to be 
measured for the 20 percent improvement in the 2020 Impact Goals. 53  
The reduction in case-fatality rates and mortality due to stroke is seen irrespective of 
sex, race and age groups in most studies, though some variations in rates of decline 
are reported. 54-56 The sustained decline in stroke mortality was coined one of the 10 
great public health achievements of the 20th century in the US, and as the decline 
continued, it was again acknowledged as a major public health achievement in the 
subsequent first decade of the 21st century. 57-59 A corresponding decline in stroke 
mortality was seen in studies worldwide. Both from combined areas such as western 
Europe 60 and Great Britain 61,62 and countries such as Brazil 63, France 64,65, Australia 
66, Israel 67 and Japan 68. However, substantial differences in improvement between 
regions and countries of different economic status have been noted, with substantial 
improvement in the most developed regions and less improvement in developing 
regions. 28,31,69 In addition the studies performed in low-income and middle-income 
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countries are generally of lower methodological quality and the data regarding 
national disease incidence and mortality is markedly less complete. 28,31
The improved treatment of blood pressure starting with the results of the Veterans 
Administration trials in the 1960s, has been awarded credit for the reduction in rate of 
death due to stroke. 70,71 Increased use of effective treatments alongside 
implementation of individual screening and public health efforts to improve lifestyle 
as a combined effort have proven very successful. 58 Hypertension is recognized as 
the treatable factor with the highest contributing factor to overall stroke risk and is 
together with lifestyle factors including diet, smoking, physical activity and 
abdominal circumference considered accountable for 82% of the population-
attributable risk for ischemic stroke. 72,73 The same report estimated 90% of the 
population-attributable risk of stroke could be explained by a total of ten key risk 
factors. The biggest contributing factor to reduced stroke mortality is considered to be 
a reduction in the case-fatality rate. 74 The introduction of thrombolysis in acute 
stroke treatment is an obvious contributing factor. 75 In populations experiencing 
increased mortality, the increase was more attributable to an increase in case-fatality 
rate than increasing incidence. 74
Time trends in stroke incidence – the age disparity
Disparities between rich and poor countries are highly apparent, and there are 
indications the disparities are increasing rather than decreasing. 31,73 However, 
disparities in the temporal progression of stroke incidence are not only apparent in 
economically inequivalent populations. Even though stroke incidence seems to be 
decreasing in total, stratification by age reveals a worrying trend among the young. 
The 2010 global burden of disease study reported an increase of mean age at first 
stroke, but since this was caused by the demographic age shift of the entire 
population the authors highlighted that the stroke burden is proportionally greater in 
individuals younger than 75 years compared to older individuals. 31  
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Incidence of both ischemic stroke and spontaneous intracerebral hemorrhage were 
reduced in high-income countries from 1990 to 2010. 76 A study evaluating stroke 
incidence in the United States from 1987 to 2011 found significant reduction in both 
incidence and mortality, but no reduction in incidence could be observed in 
individuals aged <65 years. 55 A similar disparity was observed in both Mexican 
Americans and non-Hispanic whites with a temporal decline in incidence in patients 
aged >74 years yet no reduction in incidence could be seen in patients aged 45-59 
years. 77 A nationwide US study on hospitalization rates for acute stroke between 
1995 and 2008 found increasing prevalence in hospitalization for ischemic stroke in 
the age groups 5-14 years, 15-34 years and 35-44 for both males and females, with an 
exception for the youngest females aged 5-14 years. 78 The Greater 
Cincinnati/Northern Kentucky Stroke Study showed increasing incidence of stroke in 
the young and in addition showed the proportion of total strokes occurring before 55 
years of age increased from 12.9% to 18.6% in just one decade. 41 This was even 
ensued by a significant reduction in mean age at first stroke from 71.2 to 69.2 years. 
41  
A Swedish study of temporal trends in ischemic stroke incidence over a period of 24 
years reported increased incidences of 1.3% per year for men and 1.6% per year for 
women in young patients aged 18-44 years. 54 Whereas incidence decreased slightly 
in patients aged 45-64 years with an annual decrease of 0.4% in men and 0.6% 
women. The steepest declining rates were seen in the oldest patients aged 65-84 years 
with annual rates declining more than 3.5% as shown in Figure 5. A similar trend of 
diverging incidence rates in young versus older patients is seen in a Danish study of 
temporal trends in stroke admissions. 79 Although there are differences between males 
and females regarding several aspects of stroke, increasing young stroke incidence 
seems present in both sexes. In a study using the Swedish Hospital Discharge 
Register three year incidence rates of stroke in 30-65 year olds increased by 19% in 
men and 33% in women between 1989-1991 and 1998-2000. 80
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The Tromsø study reported time trends of stroke incidence and case-fatality in 
Northern Norway from 1977 to 2010 and found a slightly increasing incidence of 
ischemic stroke among young adults. 81  
Summarized, case-mortality is reduced in young and old alike. The efforts taken, 
predominantly in high-income countries to reduce the burden of CVD and stroke 
must be considered a great success with respect to the older age groups. Age-adjusted 
incidence and mortality of stroke have been reduced considerably among the older 
age groups. However, a similar reduction is not seen among the young. The reason 
for the diverging incidence trends of ischemic stroke in young vs. older patients is not 
known. There seems to be a disparity in the prevalence of risk factors and thereby 
risk factor acknowledgement and commencement of primary preventive ischemic 
26
stroke treatment may be harder to achieve and less frequent among the young. The 
US National Health and Nutrition Examination Survey (NHANES) shows diabetes, 
high cholesterol and obesity measured by BMI > 30 has increased in the background 
population during the two latest decades. 29,82 And although active smoking decreased 
in the background population The Greater Cincinnati/Northern Kentucky Stroke 
Study showed substance abuse increased among young stroke patients in a similar 
time period, with a significant increase in active smokers (49 % in 1993 vs 66 % in 
2005)  and users of illicit drugs (3.8 % in 1993 vs 19.8 % in 2005). 83
27
Etiology and risk factors 
Etiology of stroke 
Stroke is most commonly caused by reduced arterial blood supply leading to ischemic 
damage of neural tissue. Of all arterial strokes, 87% have an ischemic cause, 10% are 
caused by spontaneous intracranial hemorrhage (ICH) and about 3% are caused by 
subarachnoid hemorrhage (SAH). 29  
Ischemic stroke may be further subcategorized by the underlying cause of the 
ischemic damage. The most widely used etiological classification is the Trial of Org 
10172 in Acute Stroke Treatment classification (TOAST). 84 TOAST contains criteria 
to define ischemic stroke in five categories: large-artery atherosclerosis, 
cardioembolism, small vessel disease, stroke of other determined cause and stroke of 
undetermined cause. The use of TOAST is widespread and its value is well 
documented, however there are inherent problems 85 with the proportion of stroke by 
undetermined cause being as high as 40% in some studies. 86 This has led to the 
creation of alternative classification systems such as the CCS 87 (Causative 
Classification System) and ASCO 88(Atherosclerosis, Small vessel disease, Cardiac 
source, Other cause) to increase the accuracy of stroke sub-classification. However, 
varying results on the resulting classification improvements are reported. One study 
reported the percentage classified with stroke of undetermined cause was reduced 
from 39% with TOAST to 26% with CSS, while no improvement was seen when 
applying the ASCO criteria. 89 Another study compared the classification results of 
CCS and TOAST on the same population and reported no reduction in the percentage 
classified with undetermined cause, but an excellent agreement between the two 
systems. 90 However, a large study using a database of 13 596 stroke patients reported 
only moderate agreement, and no improvement in the percentage of patients 
classified as undetermined, while observing a shift in which patients were classified 
with undetermined cause. 91 The reduced comparability between classification 
systems represents a big hurdle making interpretation and combination of results 
across studies difficult.  
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A reliable and reproducible international classification system is crucial for 
epidemiological and genetic studies. To date, several alternatives are available, but 
there is no clear consensus on the optimal classification system for the etiologic 
causes of ischemic stroke.   
Atherosclerosis 
Atherosclerosis is a complex inflammatory process in the walls of blood vessels that 
develops from early childhood throughout life. 92,93 However, atherosclerosis is not 
just a consequence of aging, though the extent of atherosclerosis in the population 
increases with age. Atherosclerosis is now known as a result of dynamic 
inflammatory processes in different stages, and is seen to have a large span in speed 
of development between individuals. 94 Atherosclerosis has a genetic basis, though 
this is not completely understood. Several genetic loci have been connected with the 
development of atherosclerosis and Mendelian disorders causing accelerated and 
premature atherosclerosis have given valuable insight in both causes and 
developmental stages of atherosclerosis. 95-98 The pathogenesis involves accumulation 
of lipoprotein particles and lipoprotein aggregates in the arterial intima at the 
predilection and often branching arterial sites. 99 Monocytes adhere to and migrate 
through the endothelium, once inside the arterial intima layer they proliferate and 
differentiate into macrophages and engulf modified and oxidized lipoproteins, 
forming foam cells. 100 Accumulations of foam cells, called fatty streaks are prevalent 
even at a young age and may progress or regress, depending on stimulatory and 
inhibitory factors. 93,101,102 Among factors promoting progression is the death of foam 
cells which releases cytokines that promote inflammation, recruiting more monocytes 
leading to a self-promoting inflammatory process. 103 If inhibitory factors are 
insufficient to halt the development, the fatty streak may recruit and absorb smooth 
muscle cells and thereby facilitate the deposition of fibrous material and evolve 
further into an atheroma. 103  With cells perishing, a necrotic core develops and the 
maturing complex atherosclerotic lesion is now called an atherosclerotic plaque. 104
Vulnerable plaques are characterized by vascularization and thin fibrous caps that are 
at high risk of rupture. Rupture causes immediate cascades of reactions including 
29
platelet activation and aggregation and rapid activation of the coagulation cascade via 
tissue factor. 105 The formation of a thrombus may then block the artery in situ or 
form circulating embolic thrombi that may block arteries more distally in the arterial 
bed and induce ischemic damage due to reduced blood flow; thus leading to CVD 
events such as ischemic stroke, MI and sudden critical peripheral ischemia. 105
Traditional risk factors for stroke in the young 
The concept of risk factors for the development of CVD was introduced in the early 
post war years and is now a well-established term. 106 Risk factors have been a focus 
in research since its introduction and many of the public health achievements are due 
to improved recognition and treatment of risk factors. 57 Risk factors are usually 
defined as a trait, condition or other factor associated with an increased incidence of a 
disease. Many risk factors act on the development of disease and may thus be 
designated as causal risk factors, e.g. smoking act as a risk factor by being a causal 
factor for lung cancer. 107 Other risk factors may be correlated with increased 
incidence without causality. Age can arguably be exempt from causality as simply 
counting years from birth does not cause disease, but in providing knowledge of age 
groups at increased risk, age still adds valuable information to aid preventive 
intervention strategies.  
Traditional modifiable vascular risk factors, their prevalence and odds ratios for 
stroke in the young are listed in table 3.  
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The large prevalence ranges seen in table 3 are to a large part caused by different 
definitions of risk factors and difference in risk factor prevalence between the 
geographically diverse study-populations. 73 Additionally, considering the incidence 
of stroke and the prevalence of most risk factors increase with age, only slight 
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variations in age limits defining young stroke will have a disproportionately large 
impact on the prevalence of risk factors as seen in figure 6. 15,23
The presence of a dose-response relationship strengthens the evidence that a risk 
factor has a causal influence on a given disease, as shown for high blood pressure, 
dyslipidemia, diabetes mellitus, obesity, physical inactivity, tobacco exposure and 
diet. 44 Treatment of these seven risk factors called “Life’s Simple 7” shows a dose-
response relationship with regard to lowering subsequent risk of disease. 44 Presence 
of cardiovascular risk factors increases the risk of first time CVD and also the long 
term risk of recurrent events. 14,120  
Prevalence of risk factors increases with age and the increase steepens when patients 
exceed > 35 years of age (figure 6). 23 This pattern is seen regarding most traditional 
risk factors in a study comparing risk factor prevalence in patients aged  44 with 
patients aged 45-49 years. 15 When comparing young and middle-aged patients, no 
big difference is seen in the rate of smoking, but younger patients have a lower 
prevalence of diabetes mellitus, hypertension, dyslipidemia and atrial fibrillation. 
15,24,121 Although less prevalent, the risk factors’ relative impact on stroke seems to be 
higher in young patients, especially the impact of the risk factors hypertension and 
smoking. The reported ORs associated with these risk factors are 8.5 for hypertension 
and 2.8 for current smoking in patients of young age (  45 years) compared with ORs 
of 3.9 and 2.2 in patients aged > 45 years, thus the effect of the risk factors seem to 
gradually attenuate with age. 73 This may seem a bit contradictory; the older patient 
will in most cases have a longer time of exposure to the respective risk factor, and 
one could therefore expect to see a cumulative risk increase with increased duration 
of exposure. However, the development of disease appears to be remarkably quicker 
among young patients, exemplified by the young patients exposed to risk factors 
experiencing ischemic events at a far younger age than average. 122 This accelerated 
development in presence of risk factors may be caused by an increased susceptibility 
to the traditional risk factors, and it is suggested this is probably caused by a genetic 
predisposition to a speeded disease development. 122
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Rare risk factors for stroke in the young 
Although traditional risk factors are quite the same in stroke patients, independent of 
age, 15,123 we have seen that age has a large impact on the prevalence of these risk 
factors (figure 6). In addition, the young have a relatively higher prevalence of “rare” 
risk factors and causes of stroke. 23,124 One Finnish study found cervical arterial 
dissection was the second most frequent cause of stroke at 15 %, 15 a subsequent 
European meta-analysis reported a similar high percentage of stroke caused by 
dissection with 12.8%. 86 With more than one out of ten young patients having stroke 
due to arterial dissection the term “rare” risk factor may seem inapt, and one could 
argue if terming dissection as a high frequency risk factor in the young would be 
more appropriate. Rare risk factors and etiologies, their respective strength of 
association and highest level of evidence are presented in table 4.  
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Secondary prevention and prognosis 
Recommendations for secondary prevention are well documented regarding most 
causes of stroke. Extensive and approved guidelines are published and updated with 
regular intervals. 125 Contrary to stroke caused by atrial fibrillation or atherosclerosis, 
a primary effective preventive strategy to reduce the risk of stroke caused by or in 
presence of untraditional risk factors such as arterial dissection or patent foramen 
ovale (PFO) lack sufficient documentation. Recommendations for treatment of “rare” 
causes of stroke are included in the latest guidelines, but with a weaker level of 
recommendation and lower class of treatment effect. 125 Because of the insufficient 
evidence-based knowledge and the high rates of stroke by unknown cause in the 
young, a large proportion of young patients may get varying secondary preventive 
treatment. Several studies are recently published and others are underway to identify 
the optimal strategy for prevention of stroke in patients with arterial dissection and 
PFO. The Cervical Artery Dissection in Stroke Study (CADISS) study, a randomized 
study comparing antiplatelet and anticoagulant drugs found no difference in efficacy 
of preventing recurrent stroke or death. 126 This provided some answers in reply to the 
systematic Cochrane review problematizing the lack of data regarding treatment for 
cervical artery dissection. 127 A recent Cochrane review included three randomized 
controlled trials (RCTs) and summarized the current data comparing operative 
closure of PFO versus best medical therapy, finding no significant benefit of closure, 
but an increase in the risk of new-onset atrial fibrillation (RR 3.50, 95% CI 1.47 to 
8.35). A reduction in risk for recurrent stroke was implied with the Amplatzer PFO 
occluder, however the HR of 0.38 (95% CI 0.14 to 1.02) did not reach statistical 
significance. 128 Two studies; the CryptoCard study and the Paradoxical Embolism 
Prevention Study in Ischemic Stroke (PEPSIS) are awaiting assessment and three 
more studies; Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet 
Therapy to Prevent Stroke Recurrence (CLOSE), Device Closure Versus Medical 
Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale 
(DEFENSE-PFO) and GORE® HELEX® Septal Occluder / GORE® Septal 
Occluder for Patent Foramen Ovale Closure in Stroke Patients – (The Gore REDUCE 
Clinical Study) are still ongoing. An updated review is planned and expected when 
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additional data become available. 128 This data is highly welcomed; as several studies 
have failed to provide definitive answers regarding preventive treatment this 
underpins the need for a better understanding of the pathophysiologic and genetic 
background for the diverse etiologic entities in young stroke.   
The ischemic event at a young age is a marker of increased mortality and morbidity. 
39 A Study from western Norway found that the excess mortality in young stroke 
patients to a high degree were caused by vascular disease, as 47.6% of patients dead 
at follow up were dead due to cardiovascular disease. 39 A Dutch study found an 
excess long term risk of death associated with young stroke, and reported that 74% of 
the excess risk of death could be attributed to vascular disease. 129 One study from 
Tartu, Estonia even reported 5 year mortality rates as high as 29 %. 130Although they 
did not report on cause of death, the authors did however comment that the mortality 
due to cardiovascular causes is high in the Estonian population in general, thus 
implying cardiovascular causes are a likely cause of many of the deaths in the young 
stroke population. 130
The prevalence and degree of exposure to risk factors in addition to the etiologic 
stroke subtype according to TOAST both influence the subsequent risk of CVD 
events and mortality. 14 Patients with large-artery, small-artery and cardioembolic 
stroke are at higher risk of experiencing a subsequent stroke. Patients with large 
artery stroke suffer the highest risk of stroke, any CVD and any mortality, with a 20-
year cumulative risk for any CVD of nearly 53%. 14,23 This further supports the 
findings of cardiovascular disease as a significant contributor to the excess mortality 
seen in young stroke patients. Conversely, the most favorable categories with respect 
to recurrent events and mortality are found to be the unknown or cryptogenic 
category and the “other determined” category including arterial dissections, with 
dissections shown to be associated with a low risk of recurrent stroke, and also the 
lowest risk of other recurrent events in many studies. 14,131-133
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Sex differences in stroke 
The Framingham Heart Study (FHS) found a sex difference in lifetime risk of stroke 
among those aged 55 to 75 years, with females having five percentage points higher 
risk compared with males (15% vs. 20%) probably caused by the higher life-
expectancy of females. 134 Males seem to have a slightly higher incidence rate overall, 
but the sex discrepancy seems to vary with age as shown in figure 1. 29,38 Females 
have higher incidence before 30 years of age while male incidence exceeds female 
incidence at higher ages. 15,24A big European study on 5023 stroke patients aged 18 to 
55 years found that although males dominated the population total with 59%, females 
outnumbered males almost 2 to 1 in the age group 18-24 years, with 65% of the total. 
119 In the Greater Cincinnati/Northern Kentucky Stroke Study this pattern was also 
apparent with a 1.7 female to male incidence ratio in patients younger than 34 years 
and converging incidence ratios at higher ages. 135
Mortality due to stroke is similar before 45 years of age, but is substantially lower in 
females aged 45-74.136 The change in case fatality of stroke over time also differs 
between males and females, a temporal decline is evident in males, but not in 
females. 137 This pattern is further supported by the Heart Disease and Stroke 
statistics update from 2015 showing a slightly steeper decline in age-adjusted stroke 
mortality in males compared with females (-58.5% vs. -55.2%). 29 The absolute 
excess risk of death associated with vascular disease in the young stroke patients 
peaked at 10-15 years after stroke, and the observed peak was more pronounced in 
men compared to women. 129 Thus indicating vascular disease is a greater contributor 
to the excess long-term mortality in males compared to females. However, an 
Australian study evaluating sex differences in 1316 first ever strokes by a population 
based register found the 28 day mortality was higher in females compared with males 
with 32% vs 21%. 138 However, the difference in mortality was to a large degree 
explained by more severe strokes in female, since adjusting for this attenuated the 
association considerably. 138  
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Some risk factors are strictly sex specific such as pregnancy, sex hormones and use of 
oral contraceptives while others have differing distributions between sexes. 139 The 
risk associated with oral contraceptives is found to be associated with ethinyl 
estradiol content in a dose related pattern, meaning newer generation contraceptives 
with low dose ethinyl estradiol (e.g. 20μg) confers a very low absolute risk increase. 
140 Males more frequently have an atherosclerotic cause of ischemic stroke and 
develop atherosclerosis about 10 years earlier than females. 24,141
A sex difference in the response to intravenous rTPA treatment with greater treatment 
response in females has been shown. 142,143 However, a corresponding sex difference 
regarding intra-arterial rTPA treatment has not been shown so far. 144,145  
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Family history 
Family history and cardiovascular disease 
A positive family history (FH), prevalent among patients with CVD is considered a 
risk factor for CVD. 29,146-148 Several twin and sibling studies support the role of 
inherited factors in CVD and stroke.149 However, clustering of CVD within families 
may be caused by genetic factors directly or by a related familial aggregation of risk 
factors such as hypertension, diabetes mellitus and obesity or behavioral factors such 
as smoking, alcohol consumption and or dietary and physical activity habits. 150,151
These risk factors and behavioral habits may in turn have both genetic and 
environmental contributors. Thus, CVD and stroke must be considered as complex 
traits, and the genetic contributors can increase the risk without necessarily leading to 
an event in all cases.  
Data supporting an association between a FH of CVD and CAD is substantial.152-156
The risk of heart attack is approximately doubled if a premature, defined as onset <55 
years in fathers and <65 years in mothers, parental heart attack is reported. 146 There 
is evidence that increasing family history of CVD, i.e. multiple first degree relatives 
with CVD, confers a higher risk of own events. 157 In addition the age of parental 
event strongly influences the risk of events in offspring, with premature parental 
events conferring higher risk than events at a later stage in life. 158 A premature 
parental event even confers a higher risk for CAD among offspring before 55 years of 
age than CAD after the age of 55 in both men and women. 152 The higher risks of 
CAD with premature vs. late FH events and multiple family members with disease 
are shown in table 5.  
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A British study aimed to compare the relative effects of a FH of stroke and CHD to 
assess the impact on proband risk of stroke compared to CHD. 159 They found the 
association between a FH of CHD and patient CHD was stronger than the 
corresponding association between a FH of stroke and patient stroke. 159 Further they 
reported a clustering effect for FH of CHD, meaning more family members with 
CHD, was associated with increasing risk for CHD, whereas no such clustering effect 
was obvious for a FH of stroke. 159  
Premature PAD has been shown to be strongly associated with a family history of 
CVD, including cerebrovascular disease, CAD and PAD. 160 The same research group 
later expanded on these results by showing a positive FH of CVD conferred an almost 
threefold increase in risk of PAD (OR 2.76), independent of other risk factors such as 
smoking, thereby further elucidating the strong role of FH as a risk factor for PAD. 
161 A family history of PAD is associated with both increased prevalence and severity 
of PAD in patients. 162 Another group found an association between PAD in patients 
and a FH of CAD and PAD, with the strongest association for a FH of PAD. 163 A 
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study including patients with presumed atherosclerotic disease at one or several 
different arterial sites, i.e. stroke, CAD, PAD or abdominal aortic aneurysm found no 
increased prediction of subsequent events with a positive FH of CVD, with the 
exception that a paternal history of PAD was associated with subsequent PAD in 
patients. 164 This result indicates that high risk individuals who have already suffered 
a clinical CVD event may not experience increased risk prediction from a positive 
FH.  
Family history and stroke 
The path towards connecting a FH of CVD with increased risk of stroke with the 
same level of evidence as FH and CHD has been more difficult. Studies regarding FH 
and stroke have been hampered by a lack of diagnostic tools able to differentiate 
ischemic stroke from hemorrhagic stroke. Even though these tools are now widely 
available, studying the effect of FH on disease is contingent upon the parent 
generation and therefore the diagnostic tools available at the time of their diagnosis. 
There have been a myriad of variations in the definition of a positive FH used to 
analyze the effect of FH on stroke risk, from using a FH of MI 154, a combined history 
of stroke and or MI 165, stroke alone 166 and combining a history of fatal or non-fatal 
vascular events in addition to intermediate diseases such as HT and DM. 167-169
Although, FH today is acknowledged as a risk factor for stroke, there have been some 
contradictory results. Figure 7 shows case-control studies investigating the effect of 
FH on the risk of stroke. A newer case-control study found the risk of stroke and MI 
differed with a FH of stroke and a FH of MI, while a FH of MI was associated with 
both ischemic stroke and MI, a family history of stroke was not clearly associated 
with neither. 170 However, if multiple relatives were affected, the risk of subsequent 
stroke or MI in patients was increased. With reported stroke, either hemorrhagic or 
ischemic, in more than 40% of first degree relatives the calculated OR for stroke in 
probands was 6.78 (95% CI 1.15 - 40) whereas the  OR for MI was 8.44 (95% CI 
1.74–41). 170  
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A similar variation in the reported impact of the FH on risk of stroke can be seen in 
cohort studies. A prospective follow up of 14371 individuals found FH of stroke an 
independent predictor of incident stroke. 171 However, an Atherosclerosis Risk in 
Communities Study (ARIC) found FH was only a predictor for subclinical stroke 
detected by magnetic resonance imaging (MRI) and not for clinical stroke. 172 And 
another study found no predictive value of a FH of stroke to predict subsequent 
ischemic stroke after TIA. 173 A large and systematic meta-analysis combined the 
cohort studies and found FH a significant risk factor for stroke (figure 7). 174
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Several studies investigating the relation between stroke and FH of stroke have 
grouped ischemic stroke and cerebral hemorrhage together. 170,171,173-176 A systematic 
review 174 on the genetic epidemiology of ischemic stroke reported that none of three 
initially identified twin studies, five of 19 cohort studies and 20 of 37 case-control 
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studies separated between ischemic and hemorrhagic stroke in the proband, and of the 
final included studies only 2/9 cohort studies and 15/28 case-control studies separated 
ischemic and hemorrhagic stroke in the proband. 174 Regarding stroke in the FH, there 
are even fewer attempts to separate ischemic stroke from ICH. One case control study 
separates a FH of SAH while grouping a FH of IS and ICH together. 167 One study by 
Kubota et al. 177 separates different types of stroke in the phrasing of the question 
regarding FH but groups them together when analyzing FH. 178 Another  study by 
Graffagnino et al. 179  states that attempts were made to separate a FH of stroke due to 
infarction from a FH of stroke caused by cerebral hemorrhage, but unfortunately only 
provides combined FH data and no data with the two separated. 179 Neither of the two 
included cohort studies that specified proband stroke separated between a FH of 
ischemic versus hemorrhagic stroke. 172,180 Two newer studies, not included in the 
review, also refrained from distinguishing between a FH of ischemic and 
hemorrhagic stroke, one study 175 stating this was a result of the difficulty 
distinguishing IS from ICH by history alone. 181 However, a Framingham heart study 
did specify that only atherothrombotic stroke was included in the combined endpoint 
of several CVD events and found that a validated FH of premature CVD 
independently predicted CVD events among their middle-aged cohort participants. 146
In addition an Oxford Vascular study comparing the heritability of stroke between 
males and females did not include a known history of hemorrhagic stroke as a part of 
the FH. 182
The matter of testing an association between FH and stroke is further impeded by the 
different etiological mechanisms causing ischemic stroke that may have differing 
heredity. Indeed, a Greek study found FH of stroke an independent risk factor for 
both hemorrhagic and ischemic stroke, and a risk factor for the two TOAST subtypes; 
large-artery stroke and small-artery stroke, but not for cardioembolic or undetermined 
stroke subtype. 166 The finding that a positive FH was more frequent among large-
artery and small-artery stroke subtypes has subsequently been confirmed by a 
population study, 183 a case-control study 165 and a large meta-analysis. 174 And the 
result is consistent between ethnicities as a study with a large proportion of patients 
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from an ethnic minority showed similar results. 181 The risk associated with a positive 
FH of stroke was higher in patients presenting with large artery stroke at a young age, 
with a calculated OR of 4.5 in patients  55 y compared to a an OR of 1.9 in stroke 
patients aged  70 y. 165 This relationship was also present in small vessel stroke and 
was subsequently confirmed by another study showing the same pattern of 
association between a positive FH and young age at stroke onset. 165,183 A FH of MI is 
shown to increase the risk of ischemic stroke and is more frequent among patients 
with large-artery stroke subtype. 183 However, a recent study found no differences in 
rates of positive FH of stroke between stroke subtypes according to TOAST except 
for a lower frequency of positive FH in stroke patients with arterial dissection. 184
Another study on a patient cohort with premature CVD defined as CVD before 60 
years of age, found the risk of subsequent stroke was not increased in patients with a 
FH of CVD or with a FH of stroke only (HR 1.0, 95%CI 0.4-2.4). 164
The Family Heart Study showed that having one first-degree relative with a history of 
stroke increased the odds of stroke with 50% in both men and women. 185 The 
Framingham Heart Study showed a parental stroke before the age of 65 years was 
associated with an increased risk of stroke at any age in offspring. 186 The increased 
risk associated with a FH was significant regarding all stroke combined, ischemic 
stroke and atherothrombotic stroke both in parents and patients. 186 When adjusting 
for possible confounders the increased risk associated with a positive FH was slightly 
attenuated. 186 However, the hazard ratio for ischemic stroke was >3 times higher in 
patients with a parental history of ischemic stroke before 65 years of age. 186 Thus, a 
family history of young stroke seems to especially increase the risk of stroke at a 
young age.  
In summary, although some conflicting results have been published, the vast majority 
of data acknowledges family history as a robust risk factor for stroke, especially in 
young patients. 174,187 Albeit the increase in risk of stroke associated with a positive 
FH may not be overwhelming with a 30% to 76% increase (OR 1.3 - 1.76) as 
estimated in a review by Flossman et al. 174
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Genetics in cardiovascular disease 
Cardiovascular disease may occur sporadic or cluster within families. However, most 
CVD types do not follow a classic Mendelian inheritance where genotype = disease 
phenotype. Monogenic diseases associated with elevated risk of stroke, such as 
cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL), cerebral autosomal-recessive arteriopathy with 
subcortical infarcts and leukoencephalopathy (CARASIL), Fabry disease and familial 
hypercholesterolemia are acknowledged. 95,149,188,189 The majority of the known 
monogenic conditions are considered to be quite rare, with population prevalence of 
less than 1 per 100 000 to 2-3 per 100 000, depending on the population studied. 
189,190 Somewhat more frequent conditions, like Neurofibromatosis type 1 and familial 
Moyamoya disease may also cause stroke and are known to be found with higher 
frequencies in some populations, but the monogenic conditions combined still 
account for a very small proportion of total strokes worldwide.190,191  
One approach to investigate the genetic predisposition in predominantly polygenetic 
disorders is the genome-wide association studies (GWAS) approach; this approach is 
based on using large data material to identify genetic loci associated with disease. 192
The identification of a genetic hot spot more common among diseased, e.g. stroke 
patients gives the opportunity for further investigation of the function of the 
respective gene and gene-products.193 Several genetic markers have been identified 
both for stroke194 and CAD195 and overlap in genetic markers between the two has
been shown, especially for the large artery atherosclerosis subtype of stroke. 196  
The METASTROKE collaboration was initiated to enable large meta-analyses of 
GWAS and did verify several previously identified genetic loci to be associated with 
increased risk. 192 Further, they found that all of the associated loci were subtype 
specific. 192 This is not surprising as stroke etiology subtypes should be considered 
different entities with differing pathophysiological traits resulting in ischemic stroke 
as the common outcome. It is therefore likely that genetic loci are mostly associated 
with a single underlying etiological subtype of stroke. And conversely it will be quite 
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unlikely to find genetic loci strongly associated with stroke as a whole in these 
analyses. The authors therefore added the conclusive remark that a careful 
identification of stroke subtypes for future research would increase the possibility of 
identifying the different genetic pathophysiological mechanisms responsible for 
disease.  193
Heritability of the different ischemic stroke subtypes has been calculated from 
previously provided genome-wide data, resulting in heritability estimates of 40% for 
large-vessel stroke, 33% for cardioembolic stroke, 16% for small-vessel stroke, and 
38% for the combined endpoint of any ischemic stroke.150,197 Single nucleotide 
polymorphisms in different loci have shown association with blood pressure 
variability198 and large artery stroke.199 However the ORs associated with the non-
Mendelian genetic variants are modest at best, with the highest OR of 1.39 for a 
mutation in the HDAC9 gene on chromosome 7 reported in one review. 150 The risk 
allele frequency for this mutation was 16% and the population-attributable risks to 
any one of the genetic variants is likely to be small. 150 Thus, the value of genetic 
findings in improving cardiovascular risk prediction beyond tools incorporating 
family history has yet to be shown. 200 The international stroke genetics consortium 
has recently published two recommendation papers outlining a common standard 
methodology in standardizing case ascertainment, risk factor definitions, phenotyping 
of stroke subtype and outcome measurements across studies. 201 The second 
recommendation involves methods for biological sampling and storage in a 
biorepository to increase availability to share and conjoin data. 202 This clearly 
outlines that homogenization of study protocols and data collection both eases and 
increases comparability between studies and strengthens the reliability of results from 
pooled data.   
Verification of the cardiovascular family history 
Family history is a well proven, easily accessible and inexpensive method to obtain 
information about and evaluate the possible heredity of disease.  
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Stroke patients have by definition suffered brain damage, and in more than 80% of 
cases the damage is caused by ischemia.29 These cerebral infarctions can easily be 
detected by MRI DWI.203 It is known that a large proportion of patients will suffer 
subsequent cognitive difficulties after stroke.204,205 Even a decade after stroke, nearly 
half of stroke patients score below average on cognitive performance testing, with 
cognitive impairments in working memory, processing speed and or attention as the 
most common problems.205 The degree of cognitive impairment depends on the size 
and location of the infarcted area. Cognitive deficits can potentially reduce the 
validity of the patient-provided FH and thereby reduce its value as a tool to evaluate 
the heredity of stroke. The validity of a patient provided FH has been tested 
previously with a variety of methods, e.g. medical records and or concordance with 
family members.206-211 Varying accuracy has been reported and some patient 
characteristics have been shown to influence the accuracy. Increasing age has been 
shown to reduce the accuracy, while female sex is associated with increased accuracy 
of FH reporting.208 However, most of the studies testing the accuracy of FH were 
performed in presumably healthy cohorts, with a few exceptions assessing the 
accuracy of FH in patients with CAD.212,213 However, these participants had no or 
minor problems of cognitive impairment compared with stroke patients. A Greek 
study reported they verified the FH provided by patients in a structured interview by 
interviewing first-degree family members the same way. 166 However, no data 
regarding the accuracy of the patient provided information or the additional gain of 
this strategy was provided.166 One study on relatives´ clustering of disease and risk 
factors in stroke patients’ siblings compared with the siblings of patient spouses also 
tested the agreement between the relatives’ questionnaire and the medical history 
provided by their treating physician with an overall agreement of 97%.214 To my 
knowledge, studies testing the accuracy of information provided by patients suffering 
stroke are lacking. 
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Carotid intima-media thickness and cardiovascular 
disease  
Carotid intima-media thickness (cIMT) 
Carotid intima-media thickness (cIMT) is an ultrasound acquired measurement of a 
double-line reflex pattern representing the luminal-intimal and the medial-adventitial 
interfaces of the carotid artery. Performed on the far wall of the carotid artery this 
measurement corresponds well with IMT thickness as measured on histological 
specimens.215 Near wall IMT measurements suffers from the echogenicity of the 
adventitia masking the adventitial-medial boundary and thereby gives rise to 
systematic measurement error, in addition, near wall measurements are more 
sensitive to changes in equipment gain settings.216,217   
Methods of measuring carotid intima-media thickness
Recommendations on use of cIMT for risk assessment and prediction are somewhat 
conflicting. In 2010 the AHA/American College of Cardiology (ACC) presented 
guidelines where cIMT was given a class IIa recommendation for CVD risk 
assessment in intermediate risk asymptomatic adults. 218 The European Society of 
Hypertension/European Society of Cardiology recommends ultrasound scanning of 
the carotid arteries to detect vascular hypertrophy or atherosclerosis with a Class IIa 
recommendation and level of evidence B. 219 An update of the Mannheim Carotid 
Intima-Media Thickness and Plaque Consensus from the advisory board of the 
“Watching the Risk” symposium, published in late 2012, stated cIMT and plaque 
presence are recommended for the initial detection of CHD risk in asymptomatic 
patients if at intermediate risk and or risk factors were present. 220 However, the 2013 
guidelines recommend against the use of cIMT for risk prediction in clinical practice. 
221 This has been problematized in a recent review, in which the authors point out that 
most medical insurers deem cIMT and plaque presence investigational and the data 
insufficient to justify reimbursement of CIMT measurements for CVD risk 
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assessment. 222 They interpret the recent AHA/ACC guideline adjustment as being in 
line with this insurer policy. 222  
Several studies have shown association between cIMT and future CVD events. 222
The Kuoppio Ischaemic Heart Disease study showed 11% increased risk of MI with 
each 0.1mm increment of cIMT. 223 In the following years several large clinical 
studies like the Atherosclerosis Risk In Communities study224, the Cardiovascular 
Health Study225, the Rotterdam Study226, the Malmö Diet and Cancer Study227 and the 
Carotid Atherosclerosis Progression Study228 produced similar results showing CVD 
risk prediction with assessment of cIMT. However, when testing if cIMT adds 
additional prognostic value beyond traditional risk factor scoring, most studies have 
found little or no additional prognostic value. 229-231 The contradictory results 
regarding the value of cIMT in assessing and predicting CVD risk is further portrayed 
by the conflicting results from two meta-analyses. One meta-analysis published in 
2007 found the relative risks of cardiovascular events were increased with 1.15 with 
each 0.1mm increase in cIMT. 232 A second meta-analysis published in 2012 found no 
meaningful addition to CVD event prediction when cIMT was added to conventional 
risk prediction models. 233  
The explanation for the conflicting results and the wavering recommendations 
regarding cIMT measurements is probably caused by heterogeneous study protocols. 
222 A multitude of different cIMT measurement methods have been used in studies 
evaluating cIMT as a prognostic indicator. Some use only one measurement from one 
site, with CCA as the most common, whereas others use multiple measurements from 
one or several sites. Some have used the mean of one segment measurements whereas 
others use the mean of several IMT or the mean of maximal IMT or just the maximal 
IMT. In addition there is heterogeneity of whether plaque was included or actively 
excluded from measurements. The carotid ultrasound parameters used in studies of 
cIMT as a prognostic indicator of cardiovascular events, inclusion or exclusion of 
plaque into measurements, endpoints and the odds ratio (OR), relative risk (RR) or 
hazard ratio (HR) associated with IMT are presented in table 6. 
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Choosing one segment and one cIMT measurement representable for all research 
purposes would increase homogenization of studies and improve comparability. 
However, studies have different objectives. Therefore the one size fits all approach 
would be inadequate. Measurements of IMT from different segments of the carotid 
artery vary in their respective associations with cardiovascular risk factors. 248-250 The 
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choice of segment and method of measurement have therefore been debated.165,251,252
The Mannheim consensus concluded that measurements of cIMT should occur in a 
plaque free region.220 The British Regional Heart Study found CCA-IMT showed 
strong association with risk factors for stroke and prevalent stroke, bifurcation IMT 
on the other hand was associated with CHD risk factors and with prevalent CHD. 253
Nearly 27% of variation in CCA-IMT was explained by cardiovascular risk factors 
whereas the corresponding numbers for the BIF-IMT and ICA-IMT were 11% and 
8%, respectively. 254 Interestingly, low-density lipoprotein cholesterol was the only 
risk factor with a qualitatively stronger association with ICA-IMT in this material. 
The RADIANCE 2 study provided some evidence indicating CCA-IMT is more 
influenced by blood pressure than atherosclerosis.255 In addition, stroke and CHD has 
been shown to be associated with varying magnitude to different carotid segments in 
some studies, one linking stroke to the CCA-IMT230, and others finding CHD was 
best predicted by ICA-IMT234. A Multi-Ethnic Study of Atherosclerosis (MESA) 
study with 6562 participants evaluated six ultrasound metrics, including various 
plaque definitions and IMT measurements, and reported HRs, change in C-statistics 
and net reclassification improvement when IMT was added to a traditional 
Framingham risk stratification score. 256 All carotid ultrasound metrics were 
associated with incident CHD, and all but one gave significant net reclassification 
improvement. 256 Regarding stroke prediction, only ICA plaques encroaching  25% 
of lumen was associated with incident stroke and no ultrasound metric gave net 
reclassification improvement. A review of data regarding risk prediction found better 
prediction of CVD events with plaque than IMT alone. 222 This supports IMT 
measurements including plaque in the plaque prone segments of the bifurcation and 
internal carotid have improved CVD prediction when compared to measurements of 
common carotid IMT only. 240 Indeed, several studies looking into both IMT alone 
and carotid plaques comment that carotid plaques seem a better predictor for CVD 
than IMT alone. 222,237,244  
Limitations of the axial resolution in current ultrasound equipment make it difficult to 
evaluate meaningful progression of IMT in short time-frames. Most studies 
evaluating IMT progression have found no increased CVD prediction with 
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progression measurements. 257,258 Although one group used applied an approach with 
the maximum progression of IMT from several segments and measurements, i.e. the 
segment with the highest increase in IMT between two time-points, and found 
significant association with subsequent vascular events.252 If cIMT is to be used for 
risk prediction, it may be feasible to search for and measure the maximum pathology, 
although this may likely result in lower reproducibility of measurements. Results 
indicate that a proportion of the phenotypic IMT variation is explained by genetic 
factors, although the reported IMT variability accounted for by genes varies 
drastically between studies, from 30-66% of CCA-IMT up to 75% of ICA-IMT. 259-263
IMT is associated with genetic inheritance, whereas plaques seem to be more 
associated with risk factors. 264 This supports ICA-IMT as an appropriate measure 
when investigating a genetic component in stroke. 165,261  
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Aims of the thesis 
1. To quantify and evaluate the family history of cardiovascular disease in a 
young and middle-aged ischemic stroke population and analyze if 
demographic factors influence the reported family history. We aimed to assess 
and quantify a detailed family history of cardiovascular disease with a special 
regard to sex differences.  
2. To test the validity of the patient reported family history and to investigate 
factors associated with reduced accuracy of patient family history reports. We 
aimed to test the concordance between patients’ reported family history and 
parents’ own reports. 
3. To investigate the heredity of carotid intima-media thickness as a risk factor in 
young stroke patients. We aimed to test the association between carotid 
intima-media thickness and plaques at standardized sites and a family history 
of cardiovascular disease. We also aimed to test if the association differed 
between the three cardiovascular disease components; stroke, coronary heart 
disease and peripheral arterial disease or between the three measured carotid 
intima-media thickness segments; the common carotid artery, the carotid bulb 
and the internal carotid artery.
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Subjects and methods
All subjects in NOR-SYS have been prospectively included since September 2010. 
Patients with documented ischemic stroke, aged  60 years were registered with 
anamnestic, clinical, laboratory, anthropometric and radiological data. 265 In addition 
to the patients, the study includes biological children aged  18 years and the 
patients´ partners. Former partners were invited if he or she had a common child with 
the patient. Current partners were invited regardless of common offspring. 
Information and questionnaires were provided to all living parents if patients 
consented to contact and deemed parents able to answer the questionnaire 
satisfactorily. All papers included in the thesis are based on patients and family 
members included in NOR-SYS. 
The NOR-SYS design allows the gathering of data from three generations within the 
same family, including clinical, biometric and ultrasound data from two generations. 
The multi-generational cohort gives an opportunity to investigate ischemic arterial 
events in families of young and middle-aged ischemic stroke patients. The NOR-SYS 
cohort has a planned follow-up time of 15 years for the patient generation and 20 
years for the youngest offspring generation, and will therefore enable the merging of 
clinical prospective cohort data with clinical data of ischemic events across 
generations.  
NOR-SYS is approved by the local regional ethics committee and is conducted in 
accordance with the declaration of Helsinki. Participation in NOR-SYS is based on 
written informed consent from all participants or legal guardians. Patients were 
consecutively included throughout the inclusion period from September 1st 2010 to 
August 31st 2015. The inclusion criteria were: area of residence within the catchment 
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area of Haukeland university hospital, age between 15 and 60 years and documented 
primary ischemic stroke verified by cerebral imaging. Patients with stroke caused by 
non–arterial infarction such as SAH, ICH, sinus venous thrombosis, trauma or 
cerebral tumor with stroke as non-relevant co-diagnosis were excluded from 
participation.  
Bergen NORSTROKE  
Bergen NORSTROKE is a prospective registration that includes consecutive 
consenting patients admitted with stroke to the Department of Neurology, Haukeland 
University Hospital. Inclusion in Bergen NORSTROKE started February 2006. 
Demographics, anthropometric and clinical examination results, medical history, 
examination results, including radiology, cardiology, laboratory and neurosonology 
examinations in addition to acute and sub-acute treatment are registered on the day 
after admission and during hospital stay by a stroke neurologist (Halvor Næss). In 
addition, short-term outcome is monitored by repeated NIHSS scoring and modified 
Rankin scale at day seven or at earlier discharge. Bergen NORSTROKE is approved 
by the local regional ethics committee.  
Carotid intima-media thickness 
Carotid ultrasound was performed with a 9–3 MHz linear array transducer (Philips 
Medical Systems iU22, Bothell, WA, USA) and far wall cIMT was visualized using 
B-mode longitudinal plane scanning. Four patients were investigated by a mobile 
CX50 (Philips Medical Systems, Bothell, WA, USA) when admitted to the intensive 
care unit. The method for image acquisition and offline measurements of cIMT have 
been described in detail.265 Insonation by ultrasonography was performed at far walls 
at several angles defined by Meijer’s Carotid Arc® as 180, 150, 120 and 90 degrees 
for the right common carotid artery (CCA) and 180, 210, 240 and 270 degrees for the 
left common carotid artery, as used in a previous study. 250 This multi angle approach 
guided the insonation of the carotid bifurcation (BIF) and the internal carotid artery 
(ICA) to the angle with most pathology if any, and one picture frame from each 
segment was saved for analyses. A total of twelve picture frames with clearly 
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discernable far wall IMT were saved at the vessel end-diastole defined by using 
electrocardiogram gating. Measurements of the cIMT was analyzed offline on an 
Xcelera® work-station using the QLAB automated IMT measurement plug-in 
(Philips, Bothell, WA). A predefined area of 10mm within each picture frame was 
used for cIMT measurements. The positioning of this area was guided by a vertical 
raster superimposed on the live ultrasound image with the tip of the flow divider 
defined as the raster set point to guide positioning. The CCA, BIF and ICA were 
defined as 20-10 mm, 10-0 mm proximal and 0-10 mm distal to the tip of the flow 
divider, respectively. A high segment cIMT using the highest cIMT from either left 
or right side was calculated separately for CCA, BIF and ICA. Plaques were included 
in the cIMT measurements when present it the pre-defined picture frames. 
Ultrasound measurements were performed by 4 sonographers (Annette Fromm, 
Halvor Øygarden, Kristin Modalsli Sand and Ulrike Waje-Andreassen). All 
sonographers underwent extensive training and acquired international certification in 
ultrasound examinations according to the NOR-SYS research protocol. The training 
and certification was performed in collaboration with the University Medical Centre 
of Utrecht, The Netherlands. Accreditation and certification was mandatory prior to 
researchers including study subjects. The reliability of measurements within and 
between observers and equipment has been tested and reported previously. 249
Risk factor definitions
Diabetes mellitus, hypertension and hypercholesterolemia were considered present if 
diagnosed before hospital admission and treated either by lifestyle changes or 
medication. Blood pressure (BP) was measured in both arms using appropriate cuff 
size after 15-30 minutes rest in the supine position. The two measurements were used 
to calculate mean systolic and diastolic BP. S-glucose, s-total cholesterol, s-low 
density lipoprotein (LDL) and s-high density lipoprotein (HDL) cholesterol and 
fasting triglyceride concentrations were measured. Patients were grouped as active 
smoker, previous smoker if smoking stopped at least one year before the index stroke, 
or never smoker. The degree of tobacco exposure was defined by pack-years, i.e. 
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number of cigarette packs (20cig/pack) per day multiplied by number of years of 
active smoking. Body mass index (BMI) was calculated as weight in kilograms 
divided by height in meters squared, in hospital measurements were preferred, and if 
in hospital measurements were missing, anamnestic values were used. Waist-hip-ratio 
(WHR) was calculated by dividing waist circumference by hip circumference. 
Activity score was calculated from a self-reported mean weekly activity level during 
the last year in hours per week composed of household activities, outdoor walks and 
active exercise. The activity score was defined as an ordinal variable ranging from 0 
– 5. Inactivity and or no physical activity of significance were defined as 0, 1 defined 
regular household activity and maintenance work only, 2 defined as outdoor walks 1-
3h/week, 3 defined as outdoor walks exceeding 3h/week, 4 defined moderate to high 
intensity exercise 1-3h/week, and 5 defined moderate to high intensity exercise 
exceeding 3h/week. Alcohol consumption was defined as an ordinal variable with 
range 0-4, defined as 0-3, 4-6, 7-12, 13-20 or > 20 units consumed per week. Low 
fruit and vegetable diet was defined as patients eating less than three portions of 
either fruits or vegetables a weekly average the last year.  
Family history
The FH of CVD composed of stroke, CAD and peripheral artery disease (PAD), was 
assessed for patients´ first-degree relatives (FDRs) and patients´ grandparents using a 
face-to-face, standardized, questionnaire-based patient interview. Patients were 
interviewed within the first few days after admission and FH was considered positive 
(FH+) if the patient reported  1 FDR with CVD. The patient was designated FH 
negative (FH-) if no family members with CVD were reported. The questionnaire 
template used for patient interviews and the questionnaire template mailed to 
participating parents are attached in the appendix.
Participation and number of subjects 
Due to NOR-SYS having active patient inclusion up until August 2015 the number 
(n) of patients included in the papers differs. More patients are included with time 
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Paper III had the final number of 391 patients included during the full five year 
inclusion period of NOR-SYS from September 2010 until end of August 2015 
eligible for inclusion. However, three young stroke patients were excluded due to 
early death and lack of written consent for participation, four were adopted as 
children without any knowledge of biological FH and two patients were considered 
upon re-evaluation to not have cerebral infarctions as cause of their neurological 
symptoms and were therefore excluded. Paper III also includes NORSTROKE data to 
complement the analyses with laboratory results.  
Statistical analyses 
Descriptive statistics are given using the mean and standard deviations (SD) or by 
proportions with 95% confidence intervals (CI). Chi square test was used for 
categorical data. McNemar’s test was used for paired proportions. Continuous and 
normally distributed variables were analyzed by Student’s t-test, whereas non- 
normally distributed variables were analyzed by Wilcoxon rank-sum test. Regression 
analyses were performed with and without methods of variable selection, as 
appropriate. 
In paper I, variables previously known, or suspected to influence the reporting of FH 
were included in the regression model. 
In paper II, Spearman’s correlation was used to test for correlation. Concordance 
between patient and parent reports was tested using kappa statistics. In addition, 
specificity, sensitivity, predictive values and likelihood ratios were calculated by a 
STATA module named ‘diagt’, with patient answers as the diagnostic test and parent 
reports as the gold standard. 266 Kappa values of 0.41–0.60 were interpreted as 
moderate, 0.61–0.80 as substantial and 0.81–0.99 as near perfect concordance. 267  
In paper III, the cIMT-variables were highly skewed to the right. After testing 
multiple methods of variable transformation, the transformation of ICA-IMT by 
1/(square root of ICA-IMT) gave a distribution and residual distribution closely 
resembling  the normal distribution and was therefore chosen as the most appropriate 
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conversion for linear regression analyses. Regression analyses were performed using 
backwards stepwise selection, removing the least significant variable in each step, to 
identify the variables with the highest association with cIMT. Finally, putative 
interactions with age and sex were added to the model and tested. Missing data-points 
were preferably treated by expected value imputation when possible, and robustness 
of the preferred imputation strategy was tested by repeating the final regression 
model using low, mean and high value imputation in addition to list-wise deletion and 
subsequently analyzing the impact of the various imputation strategies on the main 
results.  
The level of significance was set at P < 0.05 for all analyses.  
STATA/SE 13.1 for Windows (both StataCorp, College Station, TX, USA) was used 
for analyses. 
Ethical considerations 
All patients or legal guardians were given both oral and written information about the 
study purpose; the intended use of the information acquired by the interview and the 
investigation results and signed a written informed consent form. All participating 
patient parents were given written information about the study when receiving the 
questionnaire, and gave written informed consent to participate in the study.  
NOR-SYS is approved by the Regional Ethics Committee of Western Norway, and is 
conducted in accordance with the Declaration of Helsinki.  
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Summary of included papers 
Background: Family history (FH) is a risk factor for cardiovascular disease, 
especially coronary artery disease (CAD). The impact on risk of stroke is less clear. 
This study investigated young and middle-aged ischemic stroke patients’ knowledge 
on FH of stroke, CAD, and peripheral artery disease (PAD) with a special regard to 
sex differences. 
Methods: From September 2010 to February 2014, all ischemic stroke patients aged 
15–60 years were prospectively included in the Norwegian Stroke in the Young 
Study (NOR-SYS). FH of stroke, CAD and PAD in offspring, siblings, parents, and 
grandparents was assessed using a standardized face-to-face interview. In addition to 
‘yes’ and ‘no’, the optional reply ‘don’t know’ was included to improve accuracy. 
McNemar’s test was used to compare paired proportions, i.e. FH in male vs. female 
relatives. Multiple logistic regression analyses were used to test the influence of 
patient sex on FH reporting and to adjust for possible confounding factors. 
Results: Altogether 257 patients were included. Mean age was 49.5 years and 68.1% 
were males. FH of cardiovascular disease was reported by 59% of patients. When 
asked about FH of stroke, 48 (18.7%) and 46 (17.9%) patients reported yes, whereas 
17 (6.6%) and 9 (3.5%) reported ‘don’t know’ regarding father and mother 
respectively. Similarly patients reported ‘don’t know’ regarding 117 (45.5%) paternal 
vs. 83 (32.4%) maternal grandmothers (p < 0.001). Female patients reported less 
‘don’t know’ and were more likely to report a positive cardiovascular FH than males 
(OR: 3.4; 95% CI: 1.5 to 7.7; p = 0.004). Patients had more detailed knowledge about 
CAD than stroke in fathers (p < 0.001), mothers (p < 0.001) and siblings (p = 0.01). 
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Conclusions: Young and middle-aged stroke patients reported a high FH burden of 
cardiovascular disease. Females are more likely to report a positive FH than males. 
Detailed knowledge on FH was best for CAD. Our results suggest sex has a big 
impact on FH knowledge. Females have more knowledge of FH than males and 
knowledge is better for relatives with a female than male linkage. 
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Background and purpose: Family history (FH) is used as a marker for inherited 
risk. Using FH for this purpose requires the FH to reflect true disease in the family. 
The aim was to analyse the concordance between young and middle-aged ischaemic 
stroke patients' reported FH of cardiovascular disease (CVD) with their parents' own 
reports. 
Methods: Ischaemic stroke patients aged 15–60 years and their eligible parents were 
interviewed using a standardized questionnaire. Information of own CVD and FH of 
CVD was registered. Concordance between patients and parents was tested by kappa 
statistics, sensitivity, specificity, predictive values and likelihood ratios. Regression 
analyses were performed to identify patient characteristics associated with non-
concordance of replies. 
Results: There was no difference in response rate between fathers and mothers 
(P = 0.355). Both parents responded in 57 cases. Concordance between patient and 
parent reports was good, with kappa values ranging from 0.57 to 0.7. The patient-
reported FH yielded positive predictive values of 75% or above and negative 
predictive values of 90% or above. The positive likelihood ratios (LR+) were 10 or 
higher and negative likelihood ratios (LR−) were generally 0.5 or lower. 
Interpretation regarding peripheral arterial disease was limited due to low parental 
prevalence. Higher age was associated with impaired concordance between patient 
and parent reports (OR 1.05; 95% CI: 1.01–1.09; P = 0.020). 
Conclusions: The FH provided by young and middle-aged stroke patients is in good 
concordance with parental reports. FH is an adequate proxy to assess inherited risk of 
CVD in young stroke patients. 
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Background and Purpose: Positive family history (FH+) is a risk factor for 
cardiovascular disease (CVD). We aimed to analyze the effect of different types of 
FH (stroke, coronary heart disease (CHD), peripheral artery disease (PAD) on carotid 
intima-media thickness (cIMT) in young ischemic stroke patients.   
Methods: First-degree FH of CVD was assessed in ischemic stroke patients  60y 
using a standardized interview. Carotid ultrasound was performed and far wall cIMT 
in three carotid artery segments was registered, representing the common carotid 
(CCA-IMT), carotid bifurcation (BIF-IMT) and the internal carotid artery (ICA-
IMT). Measurements were compared between FH+ and FH negative groups and 
stepwise backward regression analyses were performed to identify factors associated 
with increased cIMT.  
Results: During the study period 382 patients were enrolled, of which 262 (68%) 
were males and 233 (61%) reported FH of CVD. Regression analyses adjusting for 
risk factors revealed age as the most important predictor of cIMT in all segments. The 
association between FH+ and cIMT was modified by age (p = 0.014) and was 
significant only regarding ICA-IMT. FH+ was associated with increased ICA-IMT in 
patients aged < 45y (p = 0.001), but not in patients  45y (p = 0.083). The association 
with ICA-IMT was present for a FH of stroke (p = 0.034), but not a FH+ of CHD or 
PAD 
Conclusions: FH of stroke is associated with higher ICA-IMT in young ischemic 
stroke patients. Subtyping of cardiovascular FH is important to investigate heredity in 
young ischemic stroke patients.  
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General discussion 
Demographics of the NOR-SYS cohort 
Age and sex 
Our young and middle-aged ischemic stroke patient cohort includes patients ranging 
from 15-60 years. Paper III included 382 patients presenting the following 
demographics. Mean age was 49.4 years. The middle-aged patients outnumber the 
young by 3:1 with 288 patients aged 45-60 years and 94 patients aged < 45years. The 
greater number of middle-aged patients is not surprising given the steep rise in 
incidence shown after the age of 45 years. 15,29 The cohort included 262 (69 %) males. 
The sex distribution varied between age-intervals as seen in table 7. 
The observed higher rate of female patients in those aged < 30 years and the higher 
proportion of males in the older age group is consistent with previous reports. 24,135,268
The observed difference in distribution of stroke between sexes that changes across 
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age groups is proposedly caused by increased risk of stroke caused by factors 
associated with pregnancy and puerperium in young females. The slightly reduced 
rate of female stroke among the middle-aged is suggested to be the result of a 
protective effect of estrogen. These theories are discussed in several review papers on 
sex differences in stroke that find some support from epidemiological data, as seen in 
figure 3, and from animal models of ischemic stroke. 136,269  
Education and work 
The cohort was generally well educated. There was a slight discrepancy in level of 
education  between FH+  and FH- patients among the young with 60 % college or 
university alumni in the FH- group compared with only 30% of those with a positive 
FH (p = 0.017). A study on alcohol intake and the risk of cerebral infarction in young 
women found the young females stroke patients were generally well-educated, they 
found no difference in percentage of young stroke cases having less than high-school 
education as compared with controls, with 14.9% vs 12.5%, respectively. 270 The 
recorded high level of education is comparable to national statistics on education 
level, where around 80 % of the young have upper secondary school or tertiary 
education level. 271
Full time work or other full time occupation such as students and pupils were most 
common in both the young and the middle-aged with 78% of the young and 65% of 
the middle aged. In Hordaland County the average unemployment rate in the age-
group 15-74 years was 2.3% from 2010 to 2014, and the population percentage 
receiving pensions or benefits have been slightly increasing from 20.8% in 2010 to 
22.6% in 2014 due to an increasing number on age related pensions. 272 Thus, we see 
no large differences in employment status between the population average and the 
reported numbers in our cohort. No significant difference in working status was seen 
between the FH+ and the FH- in the young or middle-aged. 
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Anthropometric, biologic and behavioral risk factors 
There were no significant differences in BMI between the young and middle-aged or 
the FH+ and FH- groups.  When defining obesity as BMI > 30 we found that 100 
(26%) patients in the cohort were obese. This is comparable with a large European 
study of young stroke patients showing 22.3% of patients were obese. 118 The mean 
waist-hip ratio was higher in middle-aged than young patients with 0.94 vs. 0.87 (p < 
0.001) and in the FH+ compared to the FH- (p = 0.002) However, no difference 
between FH + and FH- groups was observed in age-stratified analyses. The WHO 
defines abdominal obesity as a waist-hip ratio above 0.9 in males and 0.85 in females 
and or a BMI > 30.0. 273 When applying this definition on the NOR-SYS cohort 32 
(60.4%) of young males and 22 (53.7%) of the young females had abdominal obesity. 
In the middle-aged the corresponding numbers are 171 (81.8%) males and 52 (65.8%) 
females, showing abdominal obesity was more frequent in the middle-aged compared 
to the young (p < 0.001). A pattern of more abdominal obesity with increasing age 
has been reported, although with a converse sex related pattern with higher rates in 
females than males, consistent through all age groups. 118 Abdominal obesity is 
shown to be a substantial risk factor for stroke, and there are indications that the 
effect is greater in the young. 274 This may explain why we find a high proportion of 
abdominally obese patients among our young and middle-aged stroke patient cohort. 
There were no more abdominally obese patients among the FH+ when adjusting for 
age and sex.  
BP measurements were similar between FH+ and FH- groups when adjusting for age 
and sex. Lipid profile was less favorable in middle aged patients and FH+ patients 
had higher LDL when adjusting for age and sex (p = 0.016).  
There were no significant differences in alcohol consumption between young and 
middle aged or FH+ and FH- groups. Young patients had higher activity scores 
compared with middle-aged patients (p < 0.001) but no difference between FH+ and 
FH- groups was seen. Both active and previous smoking were more common in the 
middle-aged compared to the young (p = 0.002). Among the young, there were more 
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smokers among the FH+ patients, with 56 % active smokers compared to 29 % in the 
FH- group (p = 0.007). This increased proportion of smokers in the young FH+ 
group, might suggest a non-genetic clustering of smoking as a risk factor, presuming 
a large proportion of the affected parents were also smokers.  
In summary, the middle-aged have a pronouncedly worse risk-factor profile when 
compared with the young. This is in concordance with a previous NOR-SYS report 
using a preliminary material of 150 patients 249 in addition to several other studies 
reporting worsening risk factor profiles with increasing age. 24,118 The large 
discrepancy in the proportion of FH+ patients, with a disproportionate high number 
of FH+ patients among the middle aged, showed that age could be an important 
confounding factor when analyzing potential differences between the FH+ and FH- 
patients.   
Family history data  
In the total cohort there was a significant excess of deceased fathers compared to 
mothers (p <0.001). Among patients < 45 years, two patients reported that both 
parents were deceased, 16 reported a deceased father whereas 4 reported a deceased 
mother (McNemars chi-square, p = 0.007). This shows that even among patients aged 
< 45 years, there is a significant excess of deceased fathers compared to mothers. The 
higher number of deceased fathers is probably caused by males being older at birth of 
their first child compared to females. 275 In addition males have a lower life-
expectancy than females in Norway, as has also been reported from other countries. 
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In our cohort nearly all patients had siblings, only 8 (8.5%) of the young and 18 
(6.3%) of the middle-aged reported to be an only child. Among the middle-aged the 
FH+ had slightly more siblings than the FH- (p = 0.024). This is not surprising since 
a sibling is a first-degree relative included as a potential person defining a positive 
FH. Thus, a bigger family with more siblings will increase the statistical probability 
for a FH+. This underlines the importance of adjusting for family size in analyses 
including FH. 277 Thirty-nine (42.9%) of young patients reported they had no 
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children, compared with 39 (13.5%) of the middle-aged. The middle-aged had more 
children, but no difference in number of children was seen between the FH+ and FH- 
when adjusting for age and sex.  
Family history of cardiovascular disease in young and middle-aged stroke 
patients 
A FH of CVD is frequently seen in stroke patients. In paper I we found that 59% of 
patients reported any first-degree FH of CVD. When the FH is expanded to the 
second generation including grandparents, a positive FH of CVD is even more 
common with 79% of patients reporting a positive FH.  
The proportion of patients with a positive FH from the complete NOR-SYS cohort 
presented in paper III is shown in young and middle-aged patients in figure 9. The 
nearly reversed proportion of FH+/FH- patients among the young vs. middle-aged 
shows that age has a significant influence on FH status. Middle-aged patients are 
more likely to report a positive FH, thus confirming the pattern of age as an 
influencing factor on FH that we found in paper I. 
The percentages of patients reporting a first-degree FH of stroke, CAD and PAD 
were 34%, 41% and 6%, respectively. A FH of stroke and CAD in particular are 
common in patients with stroke. The percentages reported in the NOR-SYS cohort 
are comparable to previous European findings, a Swedish study 175 reported that 41% 
of patients had a FH of stroke and a SIFAP1184 study reported that 37% of patients 
had a FH of stroke. The prevalence of a positive FH in these studies is quite similar, 
despite variations in patient age limits. NOR-SYS included patients aged 60 years 
and younger whereas the Swedish study had 70 years and the SIFAP1 study had 55 
years as the upper age limit.  
A systematic review and meta-analysis published in 2008 included 18 studies and 
reported the FH of stroke from both published and previously unpublished data 
showi
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The large variation may have several causes of varying importance. Firstly the 
populations studied are different. There is a large span in mean age and age range in 
the populations. Older patients have older parents with a higher prevalence of disease 
and therefore a higher frequency of positive FH. In addition, the prevalence of FH of 
stroke will vary with the baseline prevalence of stroke in the studied population, with 
a larger proportion of patients having a positive FH in populations where the baseline 
stroke prevalence is high. 31 Secondly, applying age limits on the parental event has a 
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large effect on the proportion of patients reporting a positive FH by excluding events 
occurring in elderly parents as defining events for a positive FH. Thirdly, a major 
influencing factor on the proportion of FH+ is variation in the ascertainment of FH 
events. Whether information was gathered from a single unsupervised questionnaire, 
a structured interview of the patient and or family members or from a review of 
medical records, can affect the frequency of FH. Even the phrasing of the questions 
used in an interview, and if the opportunity for doubt is included with a ‘don’t know / 
not sure’ option will probably influence a patients inclination to answer positively or 
negatively regarding his FH.  
Age and family history of cardiovascular disease 
Given the steep rise in stroke incidence with age, the effect of age increasing the 
prevalence of FH is especially pronounced regarding the FH of stroke. The study 
reporting the lowest percentage; 10.4% of stroke patients with a positive FH of stroke 
included men and women between 25 and 64 years and enforced a 60 year old age 
limit on parental events. 171 The other studies range between 12% and 43% of stroke 
patients reporting FH+ (table 7). The studies reporting the highest percentages of 
FH+, such as Liao 185 (36 %) Lindgren 285 (36 %) Thijs 184 (36 %) and Reed 283 (43 
%) span from 46 to 76 in mean patient age but have in common that they do not 
enforce age limits on the parental events. 
Age is a strong risk factor for CVD. It would therefore seem logical that with 
increasing age, the frequency of FH+ will increase as well. Thijs et al found an age 
related increase in FH+ resembling this expected pattern. 184 In patients aged <25 
years 32% (38/118) reported FH+, as did 32% (133/413) of patients aged 25-35 
years. However, 36% (1330/3701) of patients aged 35-55 years reported FH+. A 
previous study on the same material shows the rate of FH+ actually stays at almost a 
rate of 32 % up until the age of 45 and then increases in patients aged 45-55 years, 
with a FH as high as 39 % (1105/2997). 119 Regression analyses confirm the 
association between age and a positive FH. The FH prevalence increases as patients 
get older than 45 years; probably this marks the age interval where the parent 
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generation are experiencing an age related increase in CVD incidence, as reflected by 
the increased FH prevalence in the patient generation. Studies including older 
patients, report quite similar percentages of FH irrespective the advanced age of the 
investigated population. The OXVASC population had a mean patient age of 75 years 
and reported that 31% of patients had any first degree FH of stroke. 182 Therefore the 
age of patients may have an effect up until a certain age, and then levels off and does 
not contribute to a higher FH prevalence, probably because a high proportion of 
patient parents are by then already deceased. This explanation seems very likely 
given nearly 60% of fathers and 36% mothers are deceased in our relatively young 
cohort. 
We found increasing prevalence of FH with increasing age. This is also reported in 
several papers from the Sifap1 study group. 119,184 We did not systematically ascertain 
parent age at time of the event, and could not enforce age cut-offs defining premature 
parental events. We assume the Sifap1 studies do not enforce age limits on the FH, 
however they do not state explicitly whether they include FH events at all ages or if 
only premature events are included explicitly in the article reporting study methods or 
in any of the subsequently published studies. 118,184,290,291 Interestingly, a study 
enforcing an age limit of 65 years on parental events found strengthened associations 
between proband events and FH events and that the association is even stronger in 
young patients (table 9). 165 Showing the influence of FH was greater in younger 
patients and varied with etiologic subtype, the authors interpreted these findings 
saying a focus on young patients and specific etiologic subtypes would be most 
effective when investigating the genetic basis of stroke. 165  
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Similarly, a paper including two population based studies from the region of 
Oxfordshire in the United Kingdom, the OXVASC and the OCSP, found FH of 
stroke and FH of stroke or MI was more frequent in young compared to old patients 
i.e. a stronger association between FH+ and patient stroke in young patients (figure 
10). 183
78
Second generation family history 
The knowledge of FH in grandparents is substantially reduced compared to the 
knowledge of parental FH. We recorded that close to half of patients answered “don’t 
know” regarding paternal grandfathers’ history of stroke and heart disease. The 
higher rate of “don’t know” answers regarding grandparents indicates that patients 
know substantially less about disease in the grandparents than parents. Thus, 
integrating patient reported disease events in grandparents as a part of the FH seems 
to drastically reduce FH accuracy.  
There were no apparent differences in the rate of patients answering “don’t know” 
between stroke, heart disease and PAD in grandparents, except the rate of “don’t 
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know” is slightly lower regarding PAD in all grandparents. However, when the 
knowledge of grandparental disease is further detailed with follow-up questions e.g. 
concerning type of stroke, type of heart disease or ordinated treatment for PAD we 
see the pattern of reduced knowledge for grandparents gets even more pronounced. In 
addition, we see a difference between the knowledge of stroke and heart disease. In 
the group of 13-16 % of patients responding “yes” to a specific grandparent having 
heart disease, only 35 %  answer “don’t know” regarding the type of heart disease. 
Whereas, as many as 75-89 % of patients answer “don’t know” regarding type of 
stroke, even when reporting ‘yes’ to the prior question of stroke in the mentioned 
grandparent. Thus, even when patients know their grandparent has suffered a stroke, 
they do not know if that grandparent had an ischemic stroke, an ICH or a TIA. This 
may be a natural result of the diagnostics available in the grandparental generation, 
where diagnostic tools able to distinguish between ischemic stroke and ICH were less 
available than today. In addition, the introduction of thrombolytic treatment at the end 
of the 90-ies, and the implementation of use in Norway in 2003, resulted in public 
information campaigns that probably increased the public awareness of the difference 
between ischemic stroke and ICH. The reported rates of PAD in grandparents are 
low, making further analyses difficult.  
Effect of sex on the family history 
We found a higher OR of 2.5 for a first degree FH+ in females compared to males (p 
= 0.005), when adjusting for age, number of siblings and level of education. One 
possible explanation for the higher rate of positive FH in females could be that males 
know less about their family history than females do. The studies using databases or 
medical records for verification of FH bypasses this issue by not relying on the 
proband recollection of FH. To investigate the background for the observed 
discrepancy we analyzed the validity of the patient provided FH by comparing the 
patients’ reports with the reports of their parents and found that males do not report 
more erroneously regarding their FH than females do. Thus it seems that females 
report FH+ more frequently than males, and this cannot be completely explained by 
80
an increased rate of “don’t know” in males or by false negative reporting by males, as 
investigated in paper I and paper II.  
Data from the Oxford Vascular Study have shown similar results where probands of 
female sex were more likely than males to have a positive FH of stroke, with females 
having an OR of 1.4 to have at least one first-degree relative with stroke compared to 
males. 182 They further found that this disparity in FH frequency between males and 
females could be explained in full by an excess of stroke in female relatives, i.e. 
mothers and sisters. 182 The authors concluded the apparent difference in FH 
frequency between females and males could be caused by a greater heritability of 
ischemic stroke in females, caused by sex-specific genetic, epigenetic or even non-
genetic mechanisms entirely. 182 This finding was subsequently confirmed by the 
same authors in a systematic review and meta-analysis, although the effect of sex on 
FH of stroke was slightly attenuated with a pooled OR of 1.15. 187  
Thijs et al found that females more often had a stroke in the maternal than paternal 
lineage, whereas males had slightly more stroke in the paternal lineage, albeit non-
significant. 184 This finding reproduced the previously shown pattern of female-to-
female stroke transmission and showed this was also the case in a young stroke 
population. 182,187
We found a similar rate of FH of stroke in mothers and fathers. The reported FH of 
heart disease is significantly higher in fathers than mothers. The knowledge of FH 
depends on the sex of the patient and the sex of the relative. We observed a 
discrepancy regarding the knowledge of stroke in parents with 17 (6.6%) answering 
don’t know regarding stroke in fathers (6.6%) compared to 9 (3.5%) regarding 
mothers (p = 0.059). This pattern was even more pronounced when comparing 
maternal and paternal grandparents, patients systematically answered “don’t know” 
less frequent in maternal than paternal grandparents. The increased knowledge in 
female relatives with a link is evident also when comparing grandfathers and 
grandmothers of the same relation with each other. “Don’t know” is answered more 
frequently for the male relative, regarding all diseases except CHD. A female-female 
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relation and even a male-female relation gives increased knowledge of the FH when 
compared to a male-male relation. It seems that the involvement of females on any 
level increases the knowledge of FH. This was also observed in a qualitative semi-
structured interview based study which reported that females gave more detailed 
accounts of their family history with less encouragement to do so. 292 They also 
observed that the female link was important to facilitate the transfer of information 
between generations, and with the death of the mother information regarding the FH 
was harder to achieve. 292 Males in addition seemed to need more affected family 
members to deem themselves as having a positive family history. 292 Of note they also 
reported that some respondents with a positive family history did not perceive 
themselves as having increased risk due to differences between themselves and the 
affected family members in for example appearance or smoking habits. 292 With 
females having more knowledge than males, this may contribute to the observed 
increased FH of stroke in females as compared to males in all studies using patient 
provided FH. 182 This may also explain why the association was attenuated in the 
subsequent meta-analysis by the same authors.187 The knowledge difference between 
sexes and especially sex of parents has been proposed to influence the observed 
maternal transmission of diabetes mellitus, as “don’t know” answers were more 
frequent regarding fathers than mothers. 293 However, this does not exclude an 
additional influence of other non-genetic, genetic and or epi-genetic factors on this 
female-female relation, both with regards to the hereditary transmission of diabetes 
and stroke. 
Knowledge of stroke vs. heart disease 
A Canadian group surveyed cardiac inpatients and outpatients to evaluate their 
knowledge of risk factors and symptoms of CHD and stroke, and found that while 
patients had adequate knowledge of MI symptoms the knowledge of symptoms 
associated with acute stroke was extremely poor. 294 Defining good knowledge as 
knowledge of two or more symptoms, they found only 31% of the cardiac patients 
had good knowledge of stroke symptoms whereas 76% had good or excellent 
knowledge of MI symptoms. 294 This discrepancy may be influenced by the patient 
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population studied, as cardiac patients will be more inclined to know symptoms of 
cardiac disease. However, as patients with MI suffer a much higher risk of stroke than 
the general population and would definitely benefit from increased knowledge of 
stroke symptoms. 295 A telephone based survey in Australia found that 35% of the 
population was able to correctly identify two or more warning signs or symptoms of 
stroke. 296 An American study from the greater Cincinnati region found more than 
40% of respondents were able to identify two or more warning signs for stroke and 
identified a favorable trend of increasing knowledge in the five-year period between 
1995 and 2000. 297 It has been a general opinion that the public has less knowledge of 
their FH of stroke than their FH of CHD. A recent Norwegian study found the 
knowledge of stroke symptoms and risk factors in a stroke and transient ischemic 
attack population was unsatisfactory. 298
A history of stroke – ischemia or bleeding 
Using the index case as a source for the FH bears the possibility of recall bias. 
Several authors have also problematized the issue that it may be difficult to 
distinguish a FH of ischemic stroke from hemorrhagic stroke with this method of FH 
ascertainment. 124,299 A Swedish study investigated if individuals with a validated 
sibling history of either ischemic or hemorrhagic stroke had higher standardized 
incidence ratios of one or both of these stroke subtypes when compared with 
unaffected sibling pairs. 299 The study design separating stroke subtypes in the sibling 
history enabled analyzes to determine if inherited risk was subtype specific. The 
study showed that having an affected sibling was associated with increased risk and 
that the association was strictly subtype specific. 299 A sibling history of ischemic 
stroke was associated with ischemic stroke with an incidence ratio of 2.14 (95% CI, 
1.21 to 3.74) and a sibling history of hemorrhagic stroke was associated with 
hemorrhagic stroke with an incidence ratio of 1.82 (95% CI, 1.21 to 2.75). 299
However, a sibling history of ischemic stroke was not associated with increased 
incidence of hemorrhagic stroke and a sibling history of hemorrhagic stroke was not 
associated with increased incidence of ischemic stroke. 299 Therefore, distinguishing 
between a FH of hemorrhagic stroke and ischemic stroke seems important to explore 
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the heredity of the stroke subtypes further. In paper I the patient reports a detailed FH 
of stroke, showing that discrimination between stroke subtypes in the FH represents a 
real problem. Patients reported a positive FH of stroke in 8 (3%) siblings, 46 (17%) 
mothers and 48 (19%) fathers. Answers on follow-up questions regarding the stroke 
subtype are displayed in table 10. 
Our results with 10-15% percent of patients answering that the first-degree relative 
with stroke had a cerebral bleeding seem to correlate well with the expected 
proportion of cerebral hemorrhages in a population with stroke. 29 The proportions of 
patients reporting the first-degree relatives’ stroke as ischemic were substantially 
lower than expected. 29 Why the patients seem to be better at reporting a FH of 
cerebral bleeding than a FH of ischemic stroke is not known. However, we speculate 
that the more dramatic clinical presentation of intracranial hemorrhage with more 
severe acute deficits and higher mortality or subsequent disability may increase the 
knowledge of this stroke subtype compared to ischemic stroke. 300
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How to get the most reliable family history 
FH history is not perfect, and there are several issues that may cause concern when 
FH is used to study heredity or assess risk. First, family history may be obtained in 
different ways, the most accessible way is to ask the patient or subject about the 
family history. This opens the possibility for recall bias, especially if the subject was 
not informed about the family members’ disease directly from the patient or 
caregiver. Receiving information from a secondary or even a tertiary source may 
further reduce the accuracy and quality of the FH. 
To reduce the problem of information bias, one can interview close relatives, 
preferably the spouse, and as many first-degree family members as possible. This 
may verify and increase the completeness of the provided family history as much as 
possible.  
Arguably, the FH obtained from physician-verified medical records with 
acknowledged diagnostic standards is the best way to assure whether the FH is 
correct. However, though these rigorous requirements are admirable and perhaps 
preferable in a research setting, they will be hard to fulfill outside of clinical family-
cohort studies like the FHS. We therefore tested the FH provided by our patients 
against the information obtained directly from their parents via a standardized 
questionnaire and showed that patients´ provided FH is in high concordance with 
parental reports. 
The use of an interview-setting to acquire FH information also allows for control and 
follow-up questions regarding the provided information. Misconceptions and 
individual interpretations of FH history and the significance of FH and impact on an 
individual’s risk for disease have been discussed previously. 292 We encountered such 
misconceptions on a regular basis, and found the face to face interview setting to be 
of high value in identifying and correcting such misconceptions. For example, a 
common answer to the question “Has your mother experienced any heart disease?” 
was “No, my mother died from cancer”. Whereas follow up questions and penetration 
of the family history could very well reveal that the mother had angina for 5 years 
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and then a MI at the age of 58. The individual’s interpretation of FH should not be 
overlooked, and requires consideration when designing or implementing systematic 
FH acquisition to be used for risk assessment or for research purposes.  
To combat these lay person misunderstandings and reduce the impact of FH 
misconceptions several approaches may be used. Standardized and structured 
interviews may be desirable in clinical series and research projects, but not applicable 
on a population basis due to the time and effort needed by qualified personnel to 
perform such interviews. For a population basis we propose that a web-based 
approach where the patient can enter and evaluate his family history and be prompted 
for follow-up questions may be an adequate solution. This allows the patient to gather 
further information from family members or physicians as the prompts can contain 
questions to obtain valuable information and verify the provided information e.g. age 
and relation to family member, follow up questions about the disease to verify the 
events and increase validity. In conjunction with direct links to treatment and lifestyle 
advice, this will enable individuals to obtain information and empower them to take 
appropriate action themselves or in cooperation with a physician. Even individuals 
designated as low or intermediate risk may benefit from being educated and informed 
about the heredity and risk factors for disease.   
It seems that attaining a FH of CVD may not be as simple as one may presume. 
Although old, low-tech and well-used, new evidence suggests we have not fully 
charted the influence and insight a FH may give on risk for disease. Especially the 
previous compounding of all CVD types in one common FH may have been a fallacy. 
CVDs are conjoined by the shared pathophysiologic mechanism of atherosclerosis, 
but there may well be underlying differences we have not understood that may 
explain why some studies find differing heredity between the CVD disease entities. 
This may explain the parent PAD – patient PAD relation previously reported163, and 
the parent stroke – patient stroke relation we find regarding cIMT.  
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Value of family history 
Identifying individuals with a heritable risk of vascular events can assist in combating 
the worrying trend of increasing stroke incidence in young patients. This is 
underscored by an American study showing that although a family history of early 
stroke was present in only 11% of families, these families accounted for 86% of 
young stroke events. 301 Family history is a well acknowledged tool for risk 
assessment, although the additional value when added to complete risk assessment 
tools may be debated. The family history provides a rapid, inexpensive and easily 
accessible assessment of an individual’s risk for CVD. Regardless of the obvious 
benefits, the potential of family history as a screening tool is not yet fully utilized. 
302,303 Population awareness of heredity as a risk factor for CVD was reported to be 
unsatisfactory in a recent review, even though the population with a positive FH bears 
50-60% of the premature CHD burden. 304 The perception of a positive FH may differ 
and is affected by the closeness of the relation, age of the relative, severity of the 
event, and sex and social class of the relative and respondent. 292 Thus, a common 
understanding between patients and health professionals of heredity and conferred 
risk is crucial when assessing the FH.  
The knowledge of FH as a tool to improve preventive treatment has obvious benefits. 
Knowing of premature CVD in the family may lead to the diagnosis of familial 
hypercholesterolemia, and can improve the primary prevention for all family 
members affected by this genetic condition. Still, the benefits regarding knowledge of 
FH of CVD with non-Mendelian and probably polygenetic inheritance is not that 
clear. However, we argue that increasing the knowledge of FH as a risk factor and as 
a screening tool for identification of individuals at risk should be a prioritized goal. A 
recent study using genetic markers found increased heritability for stroke in young 
compared to older onset strokes. 305 The FH provides an opportunity for identification 
of individuals and families that suffer a high burden of the total stroke events so that 
preventive strategies may be undertaken in this group.301 Increased attention on CVD 
prevention with an approach acknowledging both hereditary factors and risk factor 
identification as means to improve preventive strategies seems feasible. A total risk 
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evaluation that considers traditional risk factors, heredity, lifestyle factors and 
patient’s conceptions regarding risk and preferences regarding treatment is needed to 
identify possible areas for intervention and choose the best non-medical or medical 
intervention strategy. The medical community involved in young stroke research 
should be especially encouraged to improve risk assessment as the individual and 
societal costs of young stroke are high and the potential for primary prevention may 
be substantial.  
Family history and carotid intima-media thickness  
We found that standardized cIMT- and plaque measurements were higher in young 
patients with a positive FH. The difference was more pronounced in the ICA (49% 
higher, p < 0.001) than the BIF (24% higher, p = 0.002) but not significant for the 
CCA. Adjusting for age and sex attenuated the coefficients associated with FH, and 
with this adjustment FH showed no statistical association with BIF-IMT. However, 
ICA-IMT was an average of 0.21mm higher in FH+ patients even when adjusting for 
age, and sex (p = 0.001). The same pattern was not evident in the middle-aged 
patients, and in the middle-aged we even saw higher ICA-IMT in the FH- patients. 
We believe that the cause for the lack of association between cIMT and FH in the 
middle-aged is a difference in what the FH represents and a reduced impact of 
genetics vs. other risk factors in the middle-aged compared with the young. 186,287,305
IMT is shown to have a stronger association with heredity than plaque. However, 
plaques seem to have a higher predictive power than IMT. This seems somewhat 
contradictory. One would expect that the risk associated with plaques in young 
patients is also caused by atherosclerotic processes and that a hereditary link should 
be present. This gap in the current knowledge requires further investigations. Initially, 
one can to some extent tackle this hurdle by allowing the inclusion of plaque 
structures in the measurement of cIMT. Although cIMT and plaque may be distinct 
entities, they share the anatomical location in the artery wall. Because of this shared 
locality, it may seem unreasonable to refrain from registering and measuring visible 
pathology when investigating the risk predictive power of carotid artery 
atherosclerotic changes.  
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Premature CVD has a strong heredity and we believe that a high proportion of young 
stroke patients have parents with premature CVD. 306 The high percentage of FH+ 
patients in the middle-aged is probably to a large degree caused by parental events at 
high age, thereby diluting the premature FH associated with a strong heredity. 
However, long-term studies such as the FHS that follow young people from FH+ and 
FH- families over a long period of time will provide us with better information about 
the impact of age of family member at event and different types of FH+ on risk of 
CVD. 
Some studies and meta-analyses have found little or no net predictive benefit of 
adding cIMT measurements to traditional risk stratification scores. 228,233,251,257
However, there are contradicting results concerning such benefit, suggesting the 
benefit is dependent on what is actually measured, and where measurements are 
obtained. Especially inclusion or exclusion of plaques seems to be of importance. The 
MESA study showed that maximum IMT measurements incorporating plaques 
independently predicted CVD events and improved risk prediction for CHD events 
when added to the Framingham score in their cohort of 6562 members with a mean 
age of 61.1 years. 256 The ARIC study showed benefit of presence of plaques in 
addition to cIMT in prediction of events. 307,308 The Three-City study showed a 
similar result and even showed the hazard ratios increased as more sites with plaques 
were acknowledged. 237 A meta-analysis including 11 studies with 54 336 subjects 
showed that plaques were more predictive of events than was cIMT alone. 309 The 
value of ultrasound evaluation of the neck arteries for risk prediction is still a matter 
of discussion. However, it becomes more and more evident that it is more important 
to find the pathology i.e. plaques, than to get an easily reproducible measurement of 
the cIMT.   
We find an association between increased ICA-IMT and a FH of stroke. It is not 
surprising that we find associations with measurements in the ICA, as this site is 
prone to plaque formation and we actively searched for and incorporated plaques in 
our measurement. This finding shows that heredity may serve as an additional way to 
identify and possibly risk stratify individuals with increased risk, possibly even 
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before a vascular event. We found that the young stroke population with a positive 
FH had increased IMT of the internal carotid artery. This gives rise to the question, 
could these patients have been identified before they had their stroke? 
To answer if there are single or several subsets of patients that are the source of 
genetic association and if a specific cut-off on the arterial measurements can be 
applied to identify these individuals requires further research. A follow up study of 
these presumed high risk patients and their families to investigate if evaluation of 
vascular changes may identify individuals at high risk, seems feasible. Identifying 
changes allows the opportunity for reasonable intervention on an individual level and 
on a bigger scale this may help to identify groups suitable for targeted information 
campaigns or other societal efforts to reduce the burden of stroke in the young. We 
encourage further research to find and evaluate any means that may assist in 
identifying young individuals with increased risk, inherited or not, as this may be a 
feasible approach to reduce the increasing burden of stroke in the young.  
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Conclusions and future directions 
Family history is the oldest tool to investigate heredity. This thesis, based on data 
from the new and prospective three-generation NOR-SYS program, brings new 
information on family history and heredity in young stroke.  
I. We showed that a positive FH of CVD is common among young and middle-
aged stroke patients. Female patients were more likely to report a positive FH 
than males. In addition to this we showed that knowledge of family history in 
the maternal lineage was higher than knowledge regarding the paternal 
lineage. Thus, sex of both the patient and the family member seem to influence 
the knowledge of FH. Patients with higher education were less likely to report 
a positive FH. Age was an important influencing factor on the prevalence of 
positive family history, with older patients more likely to report a positive FH 
than younger patients. We also showed that even today, with advanced 
diagnostic imaging available for decades, the knowledge of a FH of heart 
disease is significantly higher than the knowledge of a FH of stroke. With 
these findings we discuss the importance of taking age of patient and age of 
parent at parental event into consideration when acquiring the family history, 
and when using family history to assess heredity of CVD.  
II. The patient reported family history can be trusted when acquired in a 
systematic standardized manner, we showed this in a young and middle-aged 
ischemic stroke cohort with verified brain damage, mainly by magnetic 
resonance diffusion weighted imaging. Increasing age of patient was the only 
factor that was associated with reduced concordance between patient and 
parent reports in our study. Whereas sex of patient, level of education, 
employment and living status, alcohol consumption and smoking did not have 
a significant effect on concordance. These results imply that FH information 
acquired from the patient in a standardized systematic interview can be trusted 
as a good, albeit not perfect account of the FH.  
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III. We assessed the carotid intima-media thickness (cIMT) in the young and 
middle-aged stroke patient cohort as a surrogate measurement of 
atherosclerosis. We found a significant association between the FH of CVD 
and the cIMT of the ICA in the young but not the middle-aged. Thus it seems a 
positive FH has a large impact on atherosclerosis at a young age, whereas 
traditional risk factors may have a larger impact in middle-aged patients. We 
found this relation was only present in one segment of the artery with strongest 
association for a FH of stroke. This indicates that a detailed FH and thorough 
investigations is important in future studies of heredity. Additionally we 
discuss the possibility that the family history may represent two slightly 
different aspects of disease in the two age-categories. With the young patients 
having more premature CVD, whereas the middle-aged patients may have 
more FH of CVD associated with old age.  
We suggest that the involvement of several family members could be beneficial in 
order to obtain a valid and adequately detailed FH, including the type of and age at 
CVD event in first-degree family members. The limited knowledge regarding the 
details of the FH of stroke showed the need for educational strategies, both with a 
patient approach, and also as a public health effort to increase the knowledge of the 
FH stroke in the population.  
The FH as a tool to assess heredity may very well be completely superseded and 
made obsolete by genetic analyses in the future. However, we are not there yet. At 
this point in time, I believe the FH could and should be a supplemental aid to guide 
and improve the design of genetic studies. These two powerful tools should be 
combined in a useful and synergistic manner to improve our knowledge on the 
heredity of complex traits such as CVD. 
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Abstract
Background: Family history (FH) is a risk factor for cardiovascular disease, especially coronary artery disease (CAD).
The impact on risk of stroke is less clear. This study investigated young and middle-aged ischemic stroke patients’
knowledge on FH of stroke, CAD, and peripheral artery disease (PAD) with a special regard to sex differences.
Methods: From September 2010 to February 2014, all ischemic stroke patients aged 15–60 years were
prospectively included in the Norwegian Stroke in the Young Study (NOR-SYS). FH of stroke, CAD and PAD in
offspring, siblings, parents, and grandparents was assessed using a standardized face-to-face interview. In addition
to ‘yes’ and ‘no’, the optional reply ‘don’t know’ was included to improve accuracy. McNemar’s test was used to
compare paired proportions, i.e. FH in male vs. female relatives. Multiple logistic regression analyses were used to
test the influence of patient sex on FH reporting and to adjust for possible confounding factors.
Results: Altogether 257 patients were included. Mean age was 49.5 years and 68.1% were males. FH of
cardiovascular disease was reported by 59% of patients. When asked about FH of stroke, 48 (18.7%) and 46 (17.9%)
patients reported yes, whereas 17 (6.6%) and 9 (3.5%) reported ‘don’t know’ regarding father and mother
respectively, similarly patients reported ‘don’t know’ regarding 117 (45.5%) paternal vs. 83 (32.4%) maternal
grandmothers (p < 0.001). Female patients reported less ‘don’t know’ and were more likely to report a positive
cardiovascular FH than males (OR: 3.4; 95% CI: 1.5 to 7.7; p = 0.004). Patients had more detailed knowledge about
CAD than stroke in fathers (p < 0.001), mothers (p < 0.001) and siblings (p = 0.01).
Conclusions: Young and middle-aged stroke patients reported a high FH burden of cardiovascular disease. Females
are more likely to report a positive FH than males. Detailed knowledge on FH was best for CAD. Our results suggest
sex has a big impact on FH knowledge. Females have more knowledge of FH than males and knowledge is better
for relatives with a female than male linkage.
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Background
Family history (FH) of cardiovascular disease (CVD) in
first-degree relatives (FDRs), including stroke, coronary
artery disease (CAD) and peripheral artery disease
(PAD), is a risk factor for vascular disease [1,2]. The
association between CAD and FH of CVD is well docu-
mented [3-6]. However, the impact on risk of ischemic
stroke is less clear, although FH of CVD is a positive
predictor of stroke risk [7-10]. Sibling and genetic stud-
ies support FH of CVD as a risk factor and suggest a
genetic influence on ischemic stroke risk [11-13]. Fe-
males with stroke are more likely to have a positive
parental history than are males, and females are also
more likely to have a positive maternal than paternal
history [14,15]. Why females are more likely to report
a positive FH is unknown [16]. Earlier studies of FH
in stroke patients seldom separate between FH of
intracranial hemorrhage (ICH) and ischemic stroke, as-
suming that it would be difficult for patients to differ-
entiate between these [7-9,17-19]. Few studies included
a reply of ‘don’t know’ regarding FH, and when in-
cluded it was usually interpreted as negative, to avoid
over-estimating the FH burden [7,9]. However, one
study found that 11% answered ‘don’t know’ regarding
FH in FDRs [20]. According to Flossman et al., publi-
cations on genetic epidemiology of stroke are hetero-
geneous, insufficiently detailed and possibly biased [8].
Today, more detailed information about CVD and risk
factors is available for patients and their family mem-
bers. Diagnostic stroke imaging has improved and
increased detection of stroke [21]. Repeated efforts to
increase awareness of acute stroke symptoms have
been implemented after the introduction of thrombo-
lytic therapy [22]. Therefore the public should be bet-
ter qualified than ever to give a precise account of
their FH. As we enter the genomic era of medicine,
FH still is the most accessible, inexpensive and well
proven tool assessing inherited risk for disease [23].
This population-based study, performed in a well-
defined region of western Norway, aims to explore what
young and middle-aged ischemic stroke patients know
about stroke, CAD and PAD in their families. We aimed
to assess and quantify a detailed FH of CVD with a spe-
cial regard to sex differences.
Methods
Ischemic stroke patients aged 15–60 years who were pro-
spectively included in the population-based Norwegian
Stroke in the Young Study (NOR-SYS) were assessed.
The methods and rationale of NOR-SYS have been
described in detail previously [24]. Acute cerebral infarc-
tion was documented by magnetic resonance imaging.
Patients unable to provide an adequate FH due to severe
stroke, aphasia or severe psychiatric illness, and patients
who were adopted or had no contact with their bio-
logical family were excluded. This single-center study
has Hordaland County as catchment area, from which
all patients aged up to 60 years with suspected stroke
are admitted to the stroke unit at Haukeland univer-
sity hospital.
Patients were interviewed using a standardized ques-
tionnaire within day two or three after the diagnosis of
acute ischemic stroke. The interview was done face to
face to ensure the patient did not contact family mem-
bers by mobile phone or in any other way during the
interview; and to ensure only events recalled by the pa-
tient were registered. All registration of events was done
by the interviewing doctor. To increase reproducibility
of answers between study doctors, new interviewers par-
ticipated as a bystander in at least 5 interviews, thereby
increasing the interview similarity and minimizing differ-
ences in answer interpretation. Data regarding patient
sex, age, education, number of siblings and offspring
were registered in addition to a detailed disease history
and family history. Patients were assigned to the educa-
tional categories, basic school, high school or college/
university education. The three optional replies for the
FH disease entities of stroke, heart disease and PAD/
claudication were: ‘yes’, ‘no’ and ‘don’t know’. ‘Don’t
know’ was included to improve accuracy of reporting.
The frequency of ‘don’t know’ in FH was also analyzed
to assess the effect of patient sex on reporting of FH. In
addition, the frequency of ‘don’t know’ was analyzed to
assess differences in reporting of maternal vs. paternal
FH. The frequency of the answer ‘don’t know’ regarding
type of heart and cerebrovascular disease in FDRs was
analyzed to compare patients’ knowledge on FH of heart
disease with their knowledge on cerebrovascular disease.
All reported non-CAD, if present without any CAD, was
regarded as no CAD. FH of stroke, heart disease and
PAD in FDRs; parents, siblings and biological offspring
was registered. In addition, FH of all four grandparents
was registered.
To explore in depth knowledge and avoid misinter-
pretation of disease, further questions were asked. If the
patient replied ‘yes’ regarding FH of any of the disease
entities stroke, heart disease and PAD, he was asked to
specify the type of stroke or heart disease and in case of
PAD he was asked to specify the prescribed treatment.
When stroke was reported, the patient was asked to spe-
cify the type of stroke as a Transient Ischemic Attack
(TIA)/minor stroke with quick and complete restitution,
cerebral infarction, ICH or ‘don’t know’. When heart
disease was reported, this was specified as ischemic,
such as angina pectoris and myocardial infarction, as
non-CAD, such as arrhythmia, valve problem and heart
insufficiency or ‘don’t know’. If PAD/claudication was
reported, the patient was asked about the applied
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treatment, such as training, surgical treatment other
than amputation, amputation or ‘don’t know’. If one
answer for disease subtype was missing, the data was
imputed as ‘don’t know’.
Statistics
Descriptive statistics are given using the mean, standard
deviation (SD) and proportion with 95% confidence
interval (CI). The chi square test was used for categor-
ical data. McNemar’s test was used to compare paired
proportions. Continuous and normally distributed vari-
ables were analyzed by Student’s t-test. Wilcoxon’s
Rank-Sum Test was used to analyze continuous vari-
ables that were not normally distributed.
We stratified the patients by sex to compare FH
between males and females. FH of CVD was considered
present if at least one parent, sibling or grandparent had
CVD. Multiple logistic regression analyses with FH of
CVD as dependent variable and age, sex, educational
category and, to adjust for family size, number of sib-
lings as independent variables were performed. The
same analyses were performed using FDRs only, to
ensure that the high rates of ‘don’t know’ regarding
grandparental FH did not affect the main results. The
level of significance was set at 0.05. Stata 13.1 (Stata-
Corp, College Station, TX) was used for all analyses.
Ethics
All patients or legal guardians signed a written informed
consent. NOR-SYS is approved by the Regional Ethics
Committee of western Norway, and the study was con-
ducted in accordance with the Declaration of Helsinki.
Results
Demographics
Between September 2010 and February 2014, 292 stroke
patients were included in NOR-SYS. Two patients did
not consent, and two others were not included because
of serious psychiatric illness and mental retardation.
Thirty-five patients were excluded after inclusion. Three
(1%) were adopted and had no contact with their bio-
logical families and 32 (10.1%) were unable to answer
for themselves due to severe aphasia or coma. Partici-
pants had a mean age of 49.5 (SD = 9.3) years, 68% were
male and the majority had at least a high school educa-
tion (76%, Table 1). The mean number of siblings was
2.5 and 237 (92%) patients had at least one sibling. No
offspring stroke, CAD or PAD were reported. There
were no significant differences in demographic data by
sex, however there was a trend for age (p = 0.057), fe-
males were slightly younger than males (47.6 years vs.
50.4 years, respectively).
Family history
About 59% of participants reported their father was
deceased, while 36% reported a deceased mother (p <
0.001, Table 1). Two patients did not know if their
fathers were alive, and data regarding deceased parents
was missing in four patients. Any first-degree FH of
CVD was reported by 153 (59.5%) patients. Most partici-
pants reported a first-degree FH of CAD (41%), followed
by stroke (34%) and PAD (6%). Patients reported rela-
tively low numbers of disease and high proportions of
‘don’t know’ in grandparents for all types of CVD
(Table 2).
Table 1 Demographic data of the 257 patients included in the Stroke in the Young Study (NOR-SYS) in Bergen, Norway
2010-2014
Variables Total N = 257 Males N = 175 (68.1%) Females N = 82 (31.9%) P
Age in years, mean (SD) 49.5 (9.3) 50.4 (8.5) 47.6 (10.6) 0.057
Education 0.547
Basic school, n (%) 60 (23.5) 43 (24.7) 17 (21.0)
High school, n (%) 91 (35.7) 64 (36.8) 27 (33.3)
College/University, n (%) 104 (40.8) 67 (38.5) 37 (45.7)
N of siblings, mean (SD) 2.5 (1.7) 2.6 (1.9) 2.2 (1.3) 0.116
N of children, mean (SD) 2.0 (1.3) 2.0 (1.4) 1.8 (1.2) 0.311
Deceased fathers, n (%) 149* (58.7) 103 (59.9) 46 (56.1) 0.756
Deceased mothers, n (%) 92† (36.4) 60 (35.1) 32 (39.0) 0.542
First-degree FH of stroke, n (%) 87 (33.9) 55 (31.4) 32 (39.0) 0.230
First-degree FH of CAD, n (%) 105 (41.0) 67 (38.3) 38 (46.9) 0.192
First-degree FH of PAD, n (%) 16 (6.2) 11 (6.3) 5 (6.1) 0.954
Abbreviations: SD standard deviation, FH family history, First-degree FH family history in parents, siblings or offspring, CAD coronary artery disease, PAD peripheral
artery disease, P p-value of comparison between males and females.
*N = 254 due to missing data in 5 of patients’ fathers. †N = 252 due to missing data in 4 of patients’ mothers.
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FH knowledge regarding type of CVD
Patient reports on type of CVD in FDRs are summarized
in Table 3. Patients reported more CAD among fathers
than among mothers (p < 0.001). Detailed knowledge
regarding type of heart disease was high, whereas know-
ledge on type of parental stroke was lower. Comparing
answers regarding disease type, ‘don’t know’ type of
stroke was significantly higher than ‘don’t know’ type of
heart disease for fathers (p < 0.001), mothers (p < 0.01),
siblings (p = 0.01), and all grandparents (p < 0.001) ex-
cept mothers’ fathers (p = 0.5). Few patients reported a
FH of PAD and the knowledge of ordinated treatment
for PAD was not analyzed further.
Sex differences in FH
There was a trend of more reported FH of CVD events
and less frequent reporting of ‘don’t know’ among
females compared to males (Figure 1). When analyzing
FH of CVD in grandparents, females reported signifi-
cantly less ‘don’t know’ regarding heart disease in
mothers‘ mothers (p = 0.02) and of stroke in fathers’
mothers (p = 0.02). Patients reported ‘Yes’ or ‘No’ on FH
of stroke in both parents in 235 (91%) cases and having
knowledge of both parents’ FH was most common.
Patients consistently reported less ‘don’t know’ regarding
maternal FH than paternal FH (Table 4). Males reported
a mean number of 1.5 (SD: 1.28) family members with
CVD, whereas females reported 1.9 (SD: 1.25; p = 0.01).
Females reported a positive FH more often than males
with an OR of 3.4 (95% CI: 1.5 to 7.7; p < 0.01; Table 5).
When analyzing a positive FH in FDRs only, females are
more likely to report a positive FH with an OR of 2.5
(95% CI: 1.3 to 4.8; p < 0.01). In addition, increasing age
was associated with a positive FH and higher educational
category was associated with a negative FH.
Discussion
We observed a high rate of reported CVD in patients’
parents. The reported FH of parental stroke in the
present study was 33%, slightly lower than 41% reported
in a Swedish study [9]. The reported 37% FH of CAD in
the present study is comparable with 38% in the Swedish
study [9]. The slight disparity regarding parental stroke
may be explained by the lower mean age of our patients
Table 2 Reported family history of cardiovascular disease in first-degree relatives* and grandparents of the 257
patients included in the Stroke in Young Study (NOR-SYS) in Bergen, Norway 2010–2014
Relatives Cardiovascular disease Yes N (%) No N (%) Don’t know N (%)
Siblings† Stroke 8 (3.3) 232 (95.9) 2 (0.8)
Heart disease 36 (14.9) 202 (83.5) 4 (1.6)
PAD 5 (2.1) 232 (95.9) 5 (2.1)
Mothers Stroke 46 (17.1) 202 (78.6) 9 (3.5)
Heart disease 55 (21.6) 187 (73.3) 13 (5.1)
PAD 9 (3.5) 233 (90.7) 15 (5.8)
Fathers Stroke 48 (18.7) 192 (74.7) 17 (6.6)
Heart disease 101 (39.3) 141 (54.9) 15 (5.8)
PAD 15 (5.8) 221 (86.0) 21 (8.2)
Mothers’ mothers Stroke 30 (11.7) 143 (55.9) 83 (32.4)
Heart disease 35 (13.7) 126 (49.2) 95 (37.1)
PAD 1 (0.4) 180 (70) 76 (29.6)
Mothers’ fathers Stroke 16 (6.2) 142 (55.5) 98 (38.3)
Heart disease 47 (18.3) 113 (44.0) 97 (37.7)
PAD 3 (1.2) 173 (67.3) 81 (31.5)
Fathers’ mothers Stroke 20 (7.8) 120 (46.7) 117 (45.5)
Heart disease 21 (8.2) 121 (47.1) 115 (44.7)
PAD 5 (1.9) 167 (65.0) 85 (33.1)
Fathers’ fathers Stroke 18 (7.0) 114 (44.4) 125 (48.6)
Heart disease 34 (13.2) 108 (42.0) 115 (44.8)
PAD 4 (1.6) 156 (60.7) 97 (37.7)
Abbreviations: Stroke both ischemic events and intracranial hemorrhage, Heart disease including coronary artery disease and reported non-CAD such as heart
failure, rhythm and/or valve problems, PAD peripheral artery disease.
*No cardiovascular events were reported among offspring.
†N = 242, 242 patients had one or more siblings.
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and the methodological differences concerning the ac-
quisition of FH, where we solely interviewed patients.
The present study showed higher numbers of deceased
fathers than mothers (149 vs. 92), probably caused by
the higher life expectancy of females [25].
Earlier studies have observed a mother-daughter rela-
tionship in heredity of stroke [14]. Our results show that
females are more likely to report a positive FH than
males. Females reported a higher incidence of FH of
CVD in total and had better knowledge on the type of
Table 3 Comparing knowledge on type of cardiovascular disease in patients replying ‘Yes’ a family member suffered
from stroke, heart disease and/or peripheral artery disease
Siblings* Mothers Fathers Mothers’ mothers Mothers’ fathers Fathers’ mothers Fathers’ fathers
Stroke N = 8 N = 46 N = 48 N = 30† N = 16 N = 20 N = 18†
TIA (%) 0 (0.0) 9 (19.6) 8 (16.7) 4 (13.3) 3 (18.8) 2 (10.0) 0 (0.0)
Cerebral infarction (%) 3 (37.5) 12 (26.1) 11 (22.9) 2 (6.7) 4 (25) 2 (10.0) 2 (11.1)
Cerebral bleeding (%) 1 (12.5) 7 (15.2) 5 (10.4) 1 (3.3) 2 (12.5) 1 (5.0) 0 (0.0)
Don’t know (%) 4 (50) 18 (39.1) 24 (50) 23 (76.7) 7 (43.8) 15 (75.0) 16 (88.9)
Heart disease N = 36 N = 55† N = 101† N = 35† N = 47† N = 21 N = 34†
Angina pectoris (%) 5 (13.9) 12 (21.8) 9 (8.9) 8 (22.9) 4 (8.5) 4 (19.1) 3 (8.8)
Myocardial infarction (%) 15 (41.7) 16 (29.1) 48 (47.5) 8 (22.9) 24 (51.1) 8 (38.1) 16 (47.1)
Non-CAD (%) 12 (33.3) 21 (39.6) 25 (24.8) 7 (20) 3 (6.4) 2 (9.5) 2 (5.9)
Don’t know (%) 4 (11.1) 6 (10.9) 19 (18.8) 12 (34.3) 16 (34.0) 7 (33.3) 13 (38.2)
PAD N = 5† N = 9† N = 15 N = 1 N = 3 N = 5 N = 4
Conservative (%) 2 (40.0) 3 (33.3) 2 (13.3) 0 (0.0) 0 (0.0) 1 (20.0) 0 (0.0)
Revascularization surgery (%) 2 (40.0) 1 (11.1) 5 (33.3) 1 (100) 0 (0.0) 0 (0.0) 0 (0.0)
Amputation (%) 0 (0.0) 0 (0.0) 2 (13.3) 0 (0.0) 3 (100) 2 (40.0) 1 (25.0)
Don’t know (%) 1 (20.0) 5 (55.6) 6 (40) 0 (0.0) 0 (0.0) 2 (40.0) 3 (75.0)
From the 257 patients included in the Stroke in Young Study (NOR-SYS) in Bergen, Norway 2010-2014.
Abbreviations: TIA transient ischemic attack, Non-CAD non-coronary heart disease, included heart failure, rhythm and/or valve problems.
*N = 242, 242 patients had one or more siblings.
†One answer regarding type of disease was missing and was imputed as don’t know.
Figure 1 Reported parental history of cerebrovascular disease, coronary artery disease and peripheral artery disease from the 257
young and middle-aged ischemic stroke patients included in the Stroke in the Young Study (NOR-SYS) in Bergen, Norway 2010–2014,
stratified by sex. Answers ‘Yes’ and ‘Don’t know’ are displayed in percentage proportions with 95% confidence intervals of the total N, the
remaining answering ‘No’.
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CVD. In addition, both male and female patients know
more about their maternal than paternal FH of CVD.
Both sex of patient and maternal family linkage influ-
ence the response rate of ‘don’t know’; this suggests
that knowledge of FH is strongly influenced by sex,
possibly due to females being more involved in com-
munication across generations in Norway. Additionally,
the cultural designation of females as main family
care-givers may enable them to obtain more informa-
tion on FH of CVD [26].
Significant less reporting of ‘don’t know’ regarding dis-
ease type in maternal vs. paternal grandparents supports
the hypothesis that female-female communication on
disease across generations increases knowledge on FH.
Another possible explanation for the higher maternal
FH may be that males have a higher risk of violent death
at young age, before CVD manifestations occur [27].
And the higher female reporting of FH may be explained
by females with ischemic stroke simply having a higher
FH of CVD burden than do males. However, these
hypotheses do not explain the higher maternal than pa-
ternal FH also when comparing same-sex grandparents.
The patients reporting parental stroke had difficulties
differentiating between the types of stroke, 40% and 50%
of patients answered ‘don’t know’ regarding mothers’
and fathers’ type of stroke, respectively. The present
study was conducted 20 years after the introduction of
MRI and we assumed that the new diagnostic and treat-
ment opportunities in addition to informational cam-
paigns would have improved patients’ knowledge about
stroke. Our reported numbers of parental ICH in rela-
tion to total stroke numbers were comparable to the
relationship found in epidemiologic studies [28]. Patients
seem to clearly recall a FH of ICH, but have more prob-
lems defining an ischemic stroke in their FH. This may
be due to higher mortality and often more dramatic
symptoms of ICH [29]. It is reported that general know-
ledge on stroke is lower than knowledge on CAD,
although the knowledge about stroke symptoms was not
lower in newer studies [30,31]. Less reporting of ‘don’t
know’ on type of heart disease than on type of stroke
regarding all FDRs in our study suggests less knowledge
about stroke than CAD.
The reported FH of PAD was low in the present study;
only 15 (5.8%) of patients’ fathers had PAD. In a recent
Dutch study including 4700 patients with a history of
cerebrovascular disease, CAD, PAD or aortic abdominal
aneurysm, 16% of patients had a FH of PAD, and they
found that paternal PAD was a risk factor for subsequent
PAD in the offspring [32]. This difference may be caused
by the lower mean age of our patients, and that only
patients with ischemic stroke were included in our
study. However, the difference in prevalence of FH
shows the importance of addressing all manifestation
sites of atherosclerosis and vascular disease when evalu-
ating FH.
The reported FH of CVD among grandparents was
low. The high reporting of ‘don’t know’ regarding grand-
parents’ FH of CVD and the almost absent knowledge of
Table 5 Logistic regression displaying factors possibly associated with a positive family history of cardiovascular
disease of the 257 patients included in the Stroke in the Young Study (NOR-SYS) in Bergen, Norway 2010-2014
Response variable: FH of FDR FH of FDR + grandparents
Predictors OR 95% CI P OR 95% CI P
Sex (female) 2.50 (1.31, 4.78) 0.005 3.37 (1.48, 7.70) 0.004
Education 0.67 (0.47, 0.98) 0.038 1.20 (0.79, 1.80) 0.377
Number of siblings 1.08 (0.9, 1.27) 0.329 0.99 (0.83, 1.18) 0.922
Age of patient (years) 1.09 (1.0, 1.13) <0.001 1.03 (0.99, 1.06) 0.116
Explanations and abbreviations: FH family history, FDR first-degree relatives, i.e. parents, siblings and offspring (no cardiovascular events were reported for offspring
in this study), OR Odds ratio, CI Confidence interval, Education basic school, high school and college/university: Number of siblings: 1 unit increase per sibling
reported.
Table 4 Comparing patients answering ‘don’t know’
regarding family history of cardiovascular disease in
maternal vs. paternal family members
Relatives Maternal Paternal
CVD N (%) N (%) P*
Parent
Stroke 9 (3.50) 17 (6.61) 0.059
CAD 13 (5.06) 15 (5.84) 0.512
PAD 15 (5.84) 21 (8.17) 0.157
Grandfathers
Stroke 98 (38.13) 125 (48.64) 0.000
CAD 81 (31.52) 97 (37.74) 0.006
PAD 97 (37.74) 115 (44.75) 0.024
Grandmothers
Stroke 83 (32.30) 117 (45.53) 0.000
CAD 95 (36.96) 115 (44.75) 0.000
PAD 76 (29.57) 85 (33.07) 0.117
From the 257 patients included in the Stroke in the Young Study (NOR-SYS) in
Bergen, Norway 2010-2014.
Abbreviations: CVD Cardiovascular disease, Stroke both ischemic events and
intracranial hemorrhage, CAD coronary artery disease, PAD peripheral
artery disease.
*P-value calculated with McNemar’s test.
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grandparents’ particular CVD type suggests this may be
due to lack of knowledge on grandparental disease his-
tory and not absence of disease among grandparents.
Less available medical care and less precise diagnostics
may explain the lack of knowledge. In addition, the gen-
eration gap reduces information of grandparental FH.
The present study is strengthened by the homogenous
and well-defined study population, and also the detailed
assessment of FH including CVD subtypes and the ana-
lysis of FH from several generations. The study also has
some limitations. The well-defined study population of
young ischemic stroke patients makes the results not dir-
ectly generalizable to the general population. In addition,
the self-reported FH may not be completely correct and
is dependent on family relations, the patient cognitive
status at time of the interview and several other factors.
We excluded patients with aphasia and patients incapable
of answering themselves, but we did not assess if severity
of the acute disease could influence the answers regard-
ing FH. However, the inclusion of ‘don’t know’ as a pos-
sible answer increases the accuracy in providing a
potential answer for patients unsure of their FH.
Conclusion
In conclusion, the FH of CVD burden among young
ischemic stroke patients was high. Females seem to have
more knowledge on FH of CVD than do males, and
knowledge on maternal FH is higher than paternal FH.
Knowledge on FH of heart disease type is significantly
higher than type of stroke. We recommend obtaining
the FH with the patient as the primary informant, how-
ever, the involvement of other family members may
increase both the completeness and accuracy of the FH
and should be encouraged. More public information on
FH of CVD as a risk factor is warranted to improve the
general knowledge of FH in the population. Information
could be directed towards males in particular. As males
have less knowledge regarding own FH than females;
they have the most to gain by improving their FH know-
ledge. Increased knowledge of own FH provides an
opportunity to take action to reduce risk and may
encourage patients into smoking cessation, regular exer-
cise and adopting a healthier diet. Increased attention on
FH is important for the patient and also the public in
general to improve this accessible, well-proven and inex-
pensive tool both for risk stratification and in aiding
future genetic research.
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Background and purpose: Family history (FH) is used as a marker for inherited
risk. Using FH for this purpose requires the FH to reflect true disease in the fam-
ily. The aim was to analyse the concordance between young and middle-aged
ischaemic stroke patients’ reported FH of cardiovascular disease (CVD) with
their parents’ own reports.
Methods: Ischaemic stroke patients aged 15–60 years and their eligible par-
ents were interviewed using a standardized questionnaire. Information of own
CVD and FH of CVD was registered. Concordance between patients and par-
ents was tested by kappa statistics, sensitivity, specificity, predictive values and
likelihood ratios. Regression analyses were performed to identify patient char-
acteristics associated with non-concordance of replies.
Results: There was no difference in response rate between fathers and moth-
ers (P = 0.355). Both parents responded in 57 cases. Concordance between
patient and parent reports was good, with kappa values ranging from 0.57 to
0.7. The patient-reported FH yielded positive predictive values of 75% or
above and negative predictive values of 90% or higher. The positive likelihood
ratios (LR+) were 10 or higher and negative likelihood ratios (LR) were gen-
erally 0.5 or lower. Interpretation regarding peripheral arterial disease was lim-
ited due to low parental prevalence. Higher age was associated with impaired
concordance between patient and parent reports (odds ratio 1.05; 95% confi-
dence interval 1.01–1.09; P = 0.020).
Conclusions: The FH provided by young and middle-aged stroke patients is
in good concordance with parental reports. FH is an adequate proxy to assess
inherited risk of CVD in young stroke patients.
Introduction
A positive family history (FH) of cardiovascular
disease (CVD) in first-degree relatives confers an
increased risk of stroke and coronary artery disease
(CAD) [1–7]. FH is used as a marker for inherited
risk of disease both for cancer and CVD [8,9]. FH
can serve as a tool in identifying individuals with high
risk of developing CVD, and may aid in risk stratifi-
cation and disease prevention [9–12]. FH is usually
self-reported and the accuracy or validity of such
self-reporting has been tested in various ways, e.g. by
confirmation from medical records and by reports
from patient relatives, with varying accuracy [10,13–
16]. Higher age reduces accuracy, and female sex
seems associated with increased accuracy of FH
reporting [15]. Studies have found that under-report-
ing a FH of cancer is common and may be a problem
when assessing FH as a risk factor [17,18]. Misreport-
ing of FH could introduce bias and lead to misclassifi-
cation of patients with inherited risk, and thereby
hamper the use of FH as a tool to study the heredity
of CVD [15]. The accuracy of FH has predominantly
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been tested in healthy cohorts, with a few exceptions
assessing the accuracy of FH in patients with CAD
[19,20]. The Norwegian Stroke in the Young Study
(NOR-SYS), a prospective population-based study
conducted in a well-defined region of western Norway,
enrols young and middle-aged ischaemic stroke
patients up to 60 years of age. The patients are inter-
viewed regarding FH of stroke, CAD and peripheral
arterial disease (PAD) [21]. NOR-SYS is designed to
evaluate family patterns in the development of vascu-
lar disease using reported events, clinical examinations
(e.g. by ultrasound) and genetic analyses. As this
cohort consists of patients with documented cerebral
infarction, a need to evaluate the accuracy of the
patient-provided FH of CVD became apparent. With
standardized questionnaires sent to all eligible patient
parents providing self-reported disease history, the
aim was to analyse the concordance between patient-
and parent-reported FH.
Subjects and methods
Patients aged 15–60 years admitted to the Stroke
Unit, Department of Neurology at Haukeland
University Hospital, with acute ischaemic stroke
since September 2010 were prospectively included in
NOR-SYS. Acute cerebral infarction was confirmed
by computed tomography or magnetic resonance
imaging.
Patients were interviewed regarding FH of CVD
using a standardized questionnaire, most within 3
days after acute ischaemic stroke was diagnosed (see
Data S1). Only events recalled and reported by the
patient were registered by the interviewing doctor.
The interview was done face-to-face and contact with
family members by mobile phone or in any other way
was avoided. Only patients able to answer without
assistance were included. To increase similarity and
ensure reproducibility, all new interviewers partici-
pated as a bystander in at least five interviews,
thereby minimizing differences amongst interviewers.
The questionnaire contained detailed questions
regarding the FH of stroke, CAD and PAD in moth-
ers, fathers, siblings and all four grandparents sepa-
rately. Confirmative answers prompted follow-up
questions to further classify the disease. Patients were
assigned to the educational categories basic school,
high school and college/university education.
Patients were asked if their parents were alive and
able to fill out a similar questionnaire. Based on the
patient’s consent a similar questionnaire was sent to
the parent/parents along with a stamped return enve-
lope. The standardized parent questionnaire recorded
the parent’s own clinical events of CVD, risk factors
and medication, in addition to their parental FH of
CVD (see Data S2).
Statistics
STATA 13.1 (StataCorp, College Station, TX, USA)
was used for analyses. The chi-squared test, Wilcoxon
rank-sum test or Student’s t test was used to compare
differences in patient and parent demographics, as
appropriate. Spearman’s correlation was used to test
for correlation. Concordance was tested using kappa
statistics. In addition, specificity, sensitivity, predictive
values and likelihood ratios were calculated by a
STATA module named ‘diagt’, with patient answers
as the diagnostic test and parent reports as the gold
standard [22]. Kappa values of 0.41–0.60 were inter-
preted as moderate, 0.61–0.80 as substantial and
0.81–0.99 as near perfect concordance [23]. Regression
analyses were performed to examine if patient charac-
teristics influenced concordance. The level of signifi-
cance was set at P < 0.05.
Ethics
All participating patients and patients’ parents gave
informed written consent. The NOR-SYS protocol is
approved by the Regional Ethics Committee of west-
ern Norway, and is conducted in accordance with the
Declaration of Helsinki. The NOR-SYS protocol is
registered at http://www.clinicaltrials.gov with the
unique identifier NCT01597453.
Results
From September 2010 to August 2014, 313 acute
ischaemic stroke patients were included in NOR-SYS.
A flowchart for patient and parent eligibility and
inclusion is presented in Fig. 1. A common reason for
patients refusing the invitation of parents was parent
dementia. However, causes for refusal were not asked
for systematically. No differences in reply rates were
seen between fathers and mothers (P = 0.355). The
mean age of patients with both parents alive com-
pared with one or more deceased parents was 41.55
and 53.77 years, respectively (SD 10.50 and 6.16,
P < 0.001). The rate of parental reply was similar
between patient sexes with 87 (44.67%) male and 45
(49.5%) female patients having one or more parents
replying (P = 0.402). Spearman’s correlation revealed
a negative correlation between patient age and the
number of parent replies (r = 0.506, P < 0.001),
also present when the number of deceased parents
was adjusted for in a linear regression analysis (P <
0.001). Both parents were alive and responded in 57
© 2015 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
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(19.8%) cases. Table 1 shows the demographic data
and presence of risk factors in the 132 patients with
one or more parents replying.
Patient answers were in moderate to substantial
concordance with parental reports, with kappa values
ranging from 0.54 to 0.69 regarding stroke and CAD
(Table 2). The rate of concordance was similar
between parent sexes. The number of incorrect
answers was lowest with regard to parental PAD and
highest for parental CAD. Patient under-reporting of
FH was twice as frequent as false positive FH reports.
Positive predictive values were generally above 70%
and negative predictive values were generally above
90%, except with regard to PAD where prevalence
amongst parents was low (Table 3). Positive likeli-
hood ratios (LR+) were around 10 or higher and neg-
ative likelihood ratios (LR) were generally 0.5 or
less. Regression analyses revealed that increasing
patient age was associated with non-concordance
between patient and parent reports with an odds ratio
of 1.05 per year (95% confidence interval 1.01–1.09;
P = 0.020; Table 4). However, neither patient sex,
level of education, employment status, living status,
alcohol consumption nor smoking significantly influ-
enced concordance between patient and parent reports
(Table 4).
Discussion
A high proportion of deceased parents, especially
deceased fathers, was observed, probably due to
longer life expectancy in females and earlier debut of
CVD in males [24,25]. Stroke, CAD and PAD were
reported in 53 (18%), 42 (14%) and 10 (3%) mothers,
and 51 (18%), 93 (32%) and 18 (6%) fathers, respec-
tively (data not shown). The patients had a high
Table 1 Demographic data and presence of risk factors for cardio-
vascular disease in 132 patients included in the Norwegian Stroke in
the Young Study (NOR-SYS)
Patients N = 132
Mean age (SD) 44.5 (11.2)
Higher education (%) 65 (49.2)
Living situation
Alone 26 (19.7)
Partner/family member 106 (80.3)
Institution 1 (0.8)
Employment status
Full-time joba 103 (78.0)
Part-time job 13 (9.8)
Stay at home parent 1 (0.8)
Unemployed 4 (3.0)
Welfare benefitsb 11 (8.3)
Hypertension (%) 41 (31.1)
Diabetes mellitus (%) 5 (3.8)
Overweight (%) 88 (66.7)
Active smoker (%) 49 (37.1)
Alcohol units/week




Higher education, defined as completed college or university educa-
tion; hypertension, defined as current treatment for hypertension; dia-
betes mellitus, defined as treatment for diabetes mellitus, including
both medical and non-medical treatment; overweight, defined as body
mass index >25 kg/m2.aAlso includes self-employed, full-time students
and pupils; bincluding full welfare benefit recipients and partial benefit
recipients if no work was registered. Six cases reporting both partial
welfare benefits and part-time job were registered as part-time job.







Figure 1 Flowchart of patient and par-
ent eligibility and study inclusion.
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burden of traditional vascular risk factors, as shown
in young stroke populations in several European
regions [26]. Concordance between patient and parent
reports was good, especially with regard to stroke and
CAD. The LR+ of 19 with regard to stroke in moth-
ers tells us that a patient report of maternal stroke is
19 times more likely to concur with maternal reports
than to be a false positive report. Correspondingly the
high negative predictive values and the low LR show
that a negative patient-reported FH truly reflects no
disease event amongst first-degree family members.
Concordance was mostly acceptable also regarding
PAD. However, interpretation was limited by the low
prevalence of parental PAD. The present study shows
no difference between males and females regarding
non-concordance, indicating that the previously
reported higher frequency of positive FH in females is
not a result of more accurate FH reporting by females
[27]. This supports the previous studies showing no
difference in accuracy of FH reporting between males
and females [15,28].
Previous studies evaluating the FH of cancer show
substantial under-reporting. In probands with verified
Table 2 Patient versus parental answers regarding cardiovascular
disease history from 132 patients and 189 parents included in the
Norwegian Stroke in the Young Study (NOR-SYS)
Patients’
answers
Non-concordance (%) Kappa (SD)No Yes
Mothers’ answers
Stroke (n = 110)
No 92 3 9 (8.18) 0.62a (0.09)
Yes 6 9
CAD (n = 107)
No 89 2 10 (9.35) 0.57a (0.09)
Yes 8 8
PAD (n = 106)
No 100 2 6 (5.66) 0.03 (0.09)
Yes 4 0
Fathers’ answers
Stroke (n = 75)
No 61 2 6 (8.00) 0.68a (0.11)
Yes 4 8
CAD (n = 77)
No 49 4 9 (12.99) 0.69a (0.11)
Yes 6 18
PAD (n = 75)
No 71 1 3 (4.00) 0.38a (0.11)
Yes 2 1
CAD, coronary artery disease, defined as either myocardial infarc-
tion or angina pectoris; PAD, peripheral arterial disease, defined as
intermittent claudication or initiated treatment for peripheral arterial
disease. Some patients’ parents did not provide answers to all disease
categories as indicated by the varying number of parent replies.
aP < 0.001.
Table 3 Accuracy of 132 patient reports of cardiovascular parental disease compared with answers from 189 parents included in the Norwe-
gian Stroke in the Young Study (NOR-SYS)




(95% CI) LR+ (95% CI) LR (95% CI)
Mother Stroke 13.6% (15/110) 74.9 (48–91) 93.9 (89–97) 60.0 (32–84) 96.8 (91–99) 19.0 (6–62) 0.41 (0.2–0.8)
CAD 14.8% (16/107) 79.8 (48–94) 91.8 (97–94) 50.0 (25–75) 97.8 (92–100) 22.8 (5–97) 0.51 (0.3–0.8)
PAD 3.8% (4/106) NA 96.1 (96–96) NA (0–60) 98.0 (93–100) NA 1.02 (1.0–1.1)
Father Stroke 16.0% (12/75) 80.0 (49–94) 93.8 (87–97) 66.7 (35–90) 96.8 (89–100) 21.0 (5–87) 0.34 (0.2–0.8)
CAD 31.2% (24/77) 81.8 (63–92) 89.1 (79–94) 75.0 (53–90) 92.5 (82–98) 9.9 (4–26) 0.27 (0.1–0.5)
PAD 4.0% (3/75) 50.0 (7–93) 97.3 (94–99) 33.3 (1–91) 98.6 (92–100) 24.0 (2–298) 0.68 (0.3–1.5)
CAD, coronary artery disease, defined as either myocardial infarction or angina pectoris; CI, confidence interval; LR+, positive likelihood ratio
is the quotient of sensitivity/(1  specificity); LR, negative likelihood ratio is the quotient of (1  sensitivity)/specificity; NA, not applicable;
NPV, negative predictive value is the number of true negatives/number of negative calls; PAD, peripheral arterial disease, defined as diagnosed
or treated PAD; PPV, positive predictive value is the number of true positives/number of positive calls.
Table 4 Logistic regression analysis displaying factors associated
with non-concordance between patient-reported family history of
CVD and parents’ own reports, from 132 patients and 189 parents
included in the Norwegian Stroke in the Young Study (NOR-SYS)
OR 95% CI P value
Age (years) 1.05 1.01–1.09 0.020
Gender (female) 1.72 0.63–4.72 0.291
Education 0.77 0.42–1.38 0.378
Full-time job (reference)
Part-time job 1.09 0.28–4.37 0.895
Unemployed 0.94 0.09–10.39 0.960
Living with partner (reference)
Living with family member 1.63 0.39–6.77 0.505
Living alone 1.07 0.37–3.07 0.898
Smoking 0.75 0.44–1.26 0.272
Alcohol consumption 0.89 0.57–1.40 0.632
OR, odds ratio; CI, confidence interval; CVD, cardiovascular
disease. Full-time job also included full-time student, pupil and self-
employed; part-time job included one stay at home parent; unem-
ployed also included welfare recipients. Education, three categories:
basic school, gymnasium and college/university. Living with family
member, other than partner, e.g. child or parent.
© 2015 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
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colorectal cancer 25% of siblings reported a negative
FH of cancer [17]. Another study reported interviewee
sensitivities of 50%–60% regarding cancer in first-
degree relatives [18]. The present study with low rates
of non-concordance shows that under-reporting is
around twice as frequent as over-reporting also
regarding a FH of CVD, meaning that a patient
reports a false negative FH more often than a false
positive. However, the under-reporting of FH of CVD
varies; the NHLBI-FHS compared proband and par-
ent reports and showed 85% sensitivity for parental
CAD and substantial agreement with a kappa value
of 0.76 [15]. A MONICA sub-study verifying proband
reports with medical records showed sensitivities
regarding myocardial infarction in first-degree rela-
tives of around 68% with kappa values above 0.65 in
both cases and controls [20]. A study on healthy
undergraduates reported sensitivities of 84.2% with
regard to heart attack and 100% with regard to stroke
in parents. However, due to the low proband age the
numbers of diseased parents was low with only one
reported stroke [29]. The Framingham study reported
sensitivities of 74% for heart attack <55 years and
42% for stroke <65 years [14]. The differences in
methodology, with some applying age limits on paren-
tal disease and some using medical records to confirm
parental events, probably cause the prevalence dis-
crepancy and impair direct comparison with the pre-
sent results. Different methods for obtaining FH and
different patient characteristics probably explain the
variations in accuracy. Sending questionnaires by mail
[15] permits obtainment of FH information from fam-
ily members or other sources, thereby increasing accu-
racy and concordance between patient and family
reports. The previously reported association between
young age and high accuracy of reporting [14] is sup-
ported by the present study. Higher patient age was
associated with an incorrect FH report with an odds
ratio of 1.05 per year (P = 0.020). CVD events at
young age tend to be a more dramatic event to the
family involved. These events may therefore be more
vividly remembered and thereby lead to better cross-
generational knowledge of FH. Lastly our cohort con-
sists of patients with verified ischaemic stroke, which
it was feared would reduce the accuracy of reporting
compared to healthy individuals [2,14,15]. However,
the sensitivities and kappa values in the present study
are comparable with previous results, with 75% sensi-
tivity and a kappa value of 0.69 regarding CAD in
fathers.
The study is strengthened by the questionnaire-
based patient interview enabling control questions and
thereby increasing the accuracy of FH reports. Addi-
tional strengths are the well-defined group of young
and middle-aged patients and the mandatory verifica-
tion of ischaemic stroke. Our study has some limita-
tions. Parent information was used as the gold
standard for disease status. However, the contact
between patients and parents after the patient’s inter-
view was not limited and therefore the possibility of
joint recall bias cannot be excluded. The numbers of
eligible patients and parents were modest, in part
limited by the high numbers of deceased parents. The
study site of one hospital and the geographical catch-
ment area with predominantly Caucasian inhabitants
limits direct generalizability beyond this population.
This study shows that a detailed FH of CVD is
mostly correct when young ischaemic stroke patients
are interviewed in a standardized way by trained med-
ical professionals. Increasing age was the only demo-
graphic factor associated with reduced concordance.
FH is an inexpensive and widely available tool for
evaluating inherited risk; verifying it with parental
reports strengthens its validity [8]. The patient FH can
be used as a proxy for inherited risk of CVD in young
ischaemic stroke patients.
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